Identification	O
of	O
essential	O
GATA	B-DNA
and	O
Ets	B-DNA
binding	I-DNA
motifs	I-DNA
within	O
the	O
promoter	O
of	O
the	O
platelet	B-DNA
glycoprotein	I-DNA
Ib	I-DNA
alpha	I-DNA
gene	I-DNA
.	O

Platelet	B-protein
glycoprotein	I-protein
(	O
GP	B-protein
)	O
Ib-IX-V	B-protein
is	O
a	O
multisubunit	B-protein
adhesion	I-protein
receptor	I-protein
that	O
supports	O
platelet	O
attachment	O
to	O
thrombogenic	O
surfaces	O
at	O
sites	O
of	O
vascular	O
injury	O
.	O

The	O
congenital	O
absence	O
of	O
the	O
receptor	O
results	O
in	O
a	O
bleeding	O
disorder	O
associated	O
with	O
``	B-cell_type
giant	I-cell_type
''	I-cell_type
platelets	I-cell_type
,	O
a	O
condition	O
linking	O
the	O
expression	O
of	O
the	O
complex	O
to	O
platelet	O
morphogenesis	O
.	O

To	O
understand	O
better	O
the	O
expression	O
of	O
the	O
GP	B-protein
Ib-IX-V	I-protein
complex	I-protein
,	O
studies	O
were	O
undertaken	O
to	O
define	O
the	O
essential	O
genetic	B-DNA
elements	I-DNA
supporting	O
the	O
expression	O
of	O
the	O
alpha-subunit	B-protein
of	O
the	O
complex	O
(	O
GP	B-protein
Ib	I-protein
alpha	I-protein
)	O
.	O

GP	B-DNA
Ib	I-DNA
alpha	I-DNA
promoter	I-DNA
activity	O
was	O
evaluated	O
by	O
transfection	O
of	O
human	B-cell_type
erythroleukemia	I-cell_type
cells	I-cell_type
with	O
reporter	O
plasmids	O
coding	O
for	O
the	O
enzyme	B-protein
,	O
luciferase	B-protein
.	O

Studies	O
were	O
initiated	O
with	O
a	O
fragment	O
extending	O
2	O
,	O
738	O
nucleotides	O
5	O
'	O
to	O
the	O
transcription	B-DNA
start	I-DNA
site	I-DNA
and	O
lead	O
to	O
the	O
identification	O
of	O
253	O
nucleotides	O
retaining	O
full	O
promoter	O
activity	O
in	O
human	B-cell_type
erythroleukemia	I-cell_type
cells	I-cell_type
.	O

In	O
cells	O
of	O
nonhematopoietic	B-cell_type
lineage	I-cell_type
,	O
human	B-cell_type
endothelial	I-cell_type
and	O
HeLa	B-cell_type
cells	I-cell_type
,	O
the	O
GP	B-DNA
Ib	I-DNA
alpha	I-DNA
promoter	I-DNA
activity	O
was	O
no	O
greater	O
than	O
background	O
levels	O
obtained	O
with	O
promoterless	B-DNA
constructs	I-DNA
.	O

Gel	O
shift	O
assays	O
and	O
site-directed	O
mutagenesis	O
studies	O
defined	O
essential	O
GATA	B-DNA
and	O
Ets	B-DNA
binding	I-DNA
motifs	I-DNA
93	B-DNA
and	I-DNA
150	I-DNA
nucleotides	I-DNA
upstream	I-DNA
of	O
the	O
transcription	B-DNA
start	I-DNA
site	I-DNA
,	O
a	O
finding	O
which	O
further	O
substantiates	O
these	O
elements	O
as	O
important	O
determinants	O
of	O
megakaryocytic	O
gene	O
expression	O
.	O

The	O
results	O
define	O
essential	O
cis-acting	B-DNA
elements	I-DNA
responsible	O
for	O
the	O
expression	O
of	O
GP	B-protein
Ib	I-protein
alpha	I-protein
and	O
provide	O
insights	O
into	O
molecular	O
events	O
coinciding	O
with	O
the	O
release	O
of	O
normal	B-cell_type
platelets	I-cell_type
into	O
the	O
bloodstream	O
.	O

THE	NULL
JoUrNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

41	NULL
,	NULL
Issue	NULL
of	NULL
October	NULL
13	NULL
,	NULL
pp	NULL
.	NULL

24532-24539	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Identification	NULL
of	NULL
Essential	NULL
GATA	NULL
and	NULL
Ets	NULL
Binding	NULL
Motifs	NULL
within	NULL
the	NULL
Promoter	NULL
of	NULL
the	NULL
Platelet	NULL
Glycoprotein	NULL
Iba	NULL
Gene*	NULL
Yoshimi	NULL
Hashimoto	NULL
and	NULL
Jerry	NULL
Ware	NULL
?	NULL

$	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
May	NULL
23	NULL
,	NULL
1995	NULL
)	NULL
From	NULL
the	NULL
Roon	NULL
Research	NULL
Center	NULL
for	NULL
Arteriosclerosis	NULL
and	NULL
Thrombosis	NULL
,	NULL
Division	NULL
of	NULL
Experimental	NULL
Hemostasis	NULL
and	NULL
Thrombosis	NULL
,	NULL
Departments	NULL
of	NULL
Molecular	NULL
and	NULL
Experimental	NULL
Medicine	NULL
and	NULL
Vascular	NULL
Biology	NULL
,	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
California	NULL
92037	NULL
Platelet	NULL
glycoprotein	NULL
(	NULL
GP	NULL
)	NULL
Ib-IX-V	NULL
is	NULL
a	NULL
multisubunit	NULL
adhesion	NULL
receptor	NULL
that	NULL
supports	NULL
platelet	NULL
attachment	NULL
to	NULL
thrombogenic	NULL
surfaces	NULL
at	NULL
sites	NULL
of	NULL
vascular	NULL
injury	NULL
.	NULL

The	NULL
congenital	NULL
absence	NULL
of	NULL
the	NULL
receptor	NULL
results	NULL
in	NULL
a	NULL
bleeding	NULL
disorder	NULL
associated	NULL
with	NULL
``	NULL
giant	NULL
``	NULL
platelets	NULL
,	NULL
a	NULL
condition	NULL
linking	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
complex	NULL
to	NULL
platelet	NULL
morphogenesis	NULL
.	NULL

To	NULL
understand	NULL
better	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
GP	NULL
Ib-IX-V	NULL
complex	NULL
,	NULL
studies	NULL
were	NULL
undertaken	NULL
to	NULL
define	NULL
the	NULL
essential	NULL
genetic	NULL
elements	NULL
supporting	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
«	NULL
-subunit	NULL
of	NULL
the	NULL
complex	NULL
(	NULL
GP	NULL
Iba	NULL
)	NULL
.	NULL

GP	NULL
Ibe	NULL
promoter	NULL
activity	NULL
was	NULL
evaluated	NULL
by	NULL
transfection	NULL
of	NULL
human	NULL
erythroleukemia	NULL
cells	NULL
with	NULL
reporter	NULL
plasmids	NULL
coding	NULL
for	NULL
the	NULL
enzyme	NULL
,	NULL
luciferase	NULL
.	NULL

Studies	NULL
were	NULL
initiated	NULL
with	NULL
a	NULL
fragment	NULL
extending	NULL
2,738	NULL
nucleotides	NULL
55	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
and	NULL
lead	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
253	NULL
nucleotides	NULL
retaining	NULL
full	NULL
promoter	NULL
activity	NULL
in	NULL
human	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

In	NULL
cells	NULL
of	NULL
nonhematopoietic	NULL
lineage	NULL
,	NULL
human	NULL
endothelial	NULL
and	NULL
HeLa	NULL
cells	NULL
,	NULL
the	NULL
GP	NULL
Iba	NULL
promoter	NULL
activity	NULL
was	NULL
no	NULL
greater	NULL
than	NULL
background	NULL
levels	NULL
obtained	NULL
with	NULL
promoterless	NULL
constructs	NULL
.	NULL

Gel	NULL
shift	NULL
assays	NULL
and	NULL
site-directed	NULL
mutagenesis	NULL
studies	NULL
defined	NULL
essential	NULL
GATA	NULL
and	NULL
Ets	NULL
binding	NULL
motifs	NULL
93	NULL
and	NULL
150	NULL
nucleotides	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
a	NULL
finding	NULL
which	NULL
further	NULL
substantiates	NULL
these	NULL
elements	NULL
as	NULL
important	NULL
determinants	NULL
of	NULL
megakaryocytic	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
results	NULL
define	NULL
essential	NULL
cis-acting	NULL
elements	NULL
responsible	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
GP	NULL
Ib	NULL
«	NULL
and	NULL
provide	NULL
insights	NULL
into	NULL
molecular	NULL
events	NULL
coinciding	NULL
with	NULL
the	NULL
release	NULL
of	NULL
normal	NULL
platelets	NULL
into	NULL
the	NULL
bloodstream	NULL
.	NULL

Basic	NULL
information	NULL
on	NULL
the	NULL
differentiation	NULL
of	NULL
megakaryocytes	NULL
and	NULL
the	NULL
mechanisms	NULL
responsible	NULL
for	NULL
the	NULL
release	NULL
of	NULL
platelets	NULL
into	NULL
the	NULL
bloodstream	NULL
has	NULL
significantly	NULL
lagged	NULL
behind	NULL
basic	NULL
studies	NULL
of	NULL
other	NULL
cellular	NULL
components	NULL
of	NULL
myeloid	NULL
tissue	NULL
.	NULL

Major	NULL
reasons	NULL
for	NULL
the	NULL
lag	NULL
have	NULL
been	NULL
the	NULL
lack	NULL
of	NULL
suitable	NULL
cell	NULL
lines	NULL
mimicking	NULL
the	NULL
unique	NULL
properties	NULL
of	NULL
megakaryocytes	NULL
in	NULL
vitro	NULL
.	NULL

Certainly	NULL
,	NULL
the	NULL
recently	NULL
described	NULL
c-Mpl	NULL
ligand	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
differentiation	NULL
of	NULL
the	NULL
pluripotent	NULL
stem	NULL
cell	NULL
to	NULL
a	NULL
megakaryocyte	NULL
(	NULL
1-3	NULL
)	NULL
,	NULL
but	NULL
the	NULL
late	NULL
events	NULL
of	NULL
the	NULL
process	NULL
,	NULL
specifically	NULL
those	NULL
that	NULL
result	NULL
in	NULL
the	NULL
release	NULL
of	NULL
platelets	NULL
from	NULL
the	NULL
mature	NULL
megakaryocyte	NULL
are	NULL
still	NULL
poorly	NULL
understood	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
megakaryocytic	NULL
or	NULL
platelet-specific	NULL
antigens	NULL
is	NULL
one	NULL
unique	NULL
as	NULL
*This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
Grant	NULL
HL50545	NULL
from	NULL
the	NULL
NHLBI	NULL
of	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

This	NULL
is	NULL
publication	NULL
9391-MEM	NULL
from	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
}	NULL

Recipient	NULL
of	NULL
an	NULL
Established	NULL
Investigator	NULL
Award	NULL
from	NULL
the	NULL
American	NULL
Heart	NULL
Association	NULL
.	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
SBR8	NULL
,	NULL
10666	NULL
North	NULL
Torrey	NULL
Pines	NULL
Rd	NULL
.	NULL

,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
920837	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
619-554-9939	NULL
;	NULL
Fax	NULL
:	NULL
619-554-6779.	NULL
pect	NULL
of	NULL
megakaryocytopoiesis	NULL
and	NULL
platelet	NULL
production	NULL
that	NULL
can	NULL
be	NULL
examined	NULL
and	NULL
the	NULL
importance	NULL
of	NULL
such	NULL
studies	NULL
has	NULL
been	NULL
validated	NULL
by	NULL
the	NULL
recent	NULL
work	NULL
identifying	NULL
the	NULL
transcription	NULL
factor	NULL
,	NULL
NF-E2	NULL
,	NULL
as	NULL
an	NULL
essential	NULL
genetic	NULL
factor	NULL
for	NULL
platelet	NULL
production	NULL
(	NULL
4	NULL
)	NULL
.	NULL

A	NULL
role	NULL
for	NULL
the	NULL
platelet	NULL
membrane	NULL
receptor	NULL
,	NULL
glycoprotein	NULL
(	NULL
GP	NULL
)	NULL
Ib-IX-V	NULL
,	NULL
in	NULL
platelet	NULL
morphogenesis	NULL
is	NULL
suggested	NULL
by	NULL
the	NULL
congenital	NULL
absence	NULL
of	NULL
GP	NULL
Ib-IX-V	NULL
,	NULL
a	NULL
condition	NULL
associated	NULL
with	NULL
the	NULL
release	NULL
of	NULL
abnormal	NULL
or	NULL
``	NULL
giant	NULL
``	NULL
platelets	NULL
and	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
Bernard-Soulier	NULL
syndrome	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

The	NULL
platelet	NULL
GP	NULL
Ib-IX-V	NULL
complex	NULL
is	NULL
assembled	NULL
from	NULL
four	NULL
distinct	NULL
gene	NULL
products	NULL
,	NULL
the	NULL
a-	NULL
and	NULL
-subunits	NULL
of	NULL
GP	NULL
Ib	NULL
(	NULL
GP	NULL
Iba	NULL
and	NULL
GP	NULL
IbB	NULL
)	NULL
,	NULL
GP	NULL
IX	NULL
,	NULL
and	NULL
GP	NULL
V	NULL
(	NULL
7-11	NULL
)	NULL
.	NULL

Considerable	NULL
progress	NULL
has	NULL
been	NULL
made	NULL
defining	NULL
the	NULL
essential	NULL
role	NULL
of	NULL
this	NULL
receptor	NULL
in	NULL
hemostasis	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
,	NULL
but	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
molecular	NULL
events	NULL
and/or	NULL
factors	NULL
associated	NULL
with	NULL
the	NULL
transcription	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
individual	NULL
genes	NULL
of	NULL
the	NULL
complex	NULL
.	NULL

Moreover	NULL
,	NULL
nothing	NULL
is	NULL
known	NULL
about	NULL
the	NULL
mechanisms	NULL
which	NULL
link	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
complex	NULL
and	NULL
platelet	NULL
morphogenesis	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
supported	NULL
the	NULL
hypothesis	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
complex	NULL
on	NULL
the	NULL
megakaryocyte	NULL
,	NULL
and	NULL
ultimately	NULL
on	NULL
the	NULL
platelet	NULL
surface	NULL
,	NULL
is	NULL
dependent	NULL
upon	NULL
the	NULL
coordinated	NULL
assembly	NULL
of	NULL
at	NULL
least	NULL
three	NULL
individual	NULL
gene	NULL
products	NULL
(	NULL
14	NULL
)	NULL
.	NULL

This	NULL
implies	NULL
that	NULL
(	NULL
i	NULL
)	NULL
similar	NULL
genetic	NULL
regulatory	NULL
elements	NULL
exist	NULL
within	NULL
each	NULL
of	NULL
the	NULL
three	NULL
components	NULL
,	NULL
or	NULL
(	NULL
ii	NULL
)	NULL
the	NULL
megakaryocytic-specific	NULL
expression	NULL
of	NULL
one	NULL
,	NULL
or	NULL
perhaps	NULL
two	NULL
sub-units	NULL
,	NULL
controls	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
complete	NULL
complex	NULL
.	NULL

We	NULL
previously	NULL
reported	NULL
the	NULL
generation	NULL
of	NULL
a	NULL
transgenic	NULL
mouse	NULL
colony	NULL
expressing	NULL
the	NULL
human	NULL
gene	NULL
for	NULL
GP	NULL
Iba	NULL
as	NULL
part	NULL
of	NULL
a	NULL
human-murine	NULL
chimeric	NULL
GP	NULL
Ib-IX-V	NULL
receptor	NULL
complex	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
documented	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
transgene	NULL
and	NULL
established	NULL
among	NULL
bone	NULL
marrow	NULL
cells	NULL
that	NULL
in	NULL
vivo	NULL
gene	NULL
expression	NULL
is	NULL
dependent	NULL
upon	NULL
a	NULL
6-kilobase	NULL
DNA	NULL
sequence	NULL
containing	NULL
the	NULL
entire	NULL
human	NULL
GP	NULL
Iba	NULL
gene	NULL
.	NULL

Thus	NULL
,	NULL
within	NULL
this	NULL
fragment	NULL
are	NULL
the	NULL
promoter	NULL
and	NULL
enhancer	NULL
sequences	NULL
necessary	NULL
for	NULL
the	NULL
in	NULL
vivo	NULL
expression	NULL
of	NULL
GP	NULL
Iba	NULL
protein	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
have	NULL
extended	NULL
the	NULL
characterization	NULL
of	NULL
the	NULL
GP	NULL
Iba	NULL
gene	NULL
identifying	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
and	NULL
the	NULL
promoter	NULL
elements	NULL
responsible	NULL
for	NULL
megakaryocytic	NULL
gene	NULL
expression	NULL
.	NULL

Using	NULL
the	NULL
megakaryocytic-like	NULL
cell	NULL
line	NULL
,	NULL
HEL	NULL
(	NULL
human	NULL
erythroleukemia	NULL
cells	NULL
)	NULL
,	NULL
essential	NULL
GATA	NULL
and	NULL
Ets	NULL
consensus	NULL
sequences	NULL
were	NULL
iden-tified	NULL
,	NULL
a	NULL
finding	NULL
which	NULL
further	NULL
documents	NULL
these	NULL
elements	NULL
as	NULL
important	NULL
determinants	NULL
of	NULL
megakaryocytic	NULL
gene	NULL
expression	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
results	NULL
provide	NULL
insights	NULL
into	NULL
the	NULL
regulatory	NULL
elements	NULL
involved	NULL
in	NULL
megakaryocytic	NULL
expression	NULL
of	NULL
the	NULL
GP	NULL
Iba	NULL
gene	NULL
and	NULL
provide	NULL
a	NULL
better	NULL
understanding	NULL
of	NULL
the	NULL
events	NULL
leading	NULL
to	NULL
the	NULL
commitment	NULL
of	NULL
cells	NULL
to	NULL
the	NULL
megakaryocytic	NULL
lineage	NULL
and	NULL
the	NULL
release	NULL
of	NULL
platelets	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
GP	NULL
,	NULL
glycoprotein	NULL
;	NULL
HEL	NULL
,	NULL
human	NULL
eryth-roleukemia	NULL
;	NULL
HUVECs	NULL
,	NULL
human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
RSV	NULL
,	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
.	NULL

24532	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Functional	NULL
Analysis	NULL
of	NULL
the	NULL
Platelet	NULL
GP	NULL
Iba	NULL
Promoter	NULL
EXPERIMENTAL	NULL
PROCEDURES	NULL
Primer	NULL
Extension	NULL
Reaction-Human	NULL
erythroleukemia	NULL
cells	NULL
(	NULL
HEL	NULL
92.1.7	NULL
,	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
under	NULL
conditions	NULL
containing	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
HEL	NULL
cells	NULL
lysates	NULL
by	NULL
ultracentrifugation	NULL
through	NULL
cesium	NULL
chloride	NULL
cushions	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
®	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
affinity	NULL
chromatog-raphy	NULL
on	NULL
an	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
cellulose	NULL
column	NULL
(	NULL
Life	NULL
Technologies	NULL
Inc.	NULL
,	NULL
Gaith-ersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Two	NULL
oligonucleotides	NULL
primers	NULL
were	NULL
synthesized	NULL
for	NULL
primer	NULL
extension	NULL
analysis	NULL
.	NULL

The	NULL
first	NULL
,	NULL
RPEX1	NULL
(	NULL
83-mer	NULL
)	NULL
,	NULL
is	NULL
within	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
GP	NULL
Iba	NULL
and	NULL
corresponds	NULL
to	NULL
the	NULL
antisense	NULL
strand	NULL
of	NULL
nucleotides	NULL
2788-2820	NULL
(	NULL
numbering	NULL
according	NULL
to	NULL
the	NULL
genomic	NULL
sequence	NULL
reported	NULL
in	NULL
Ref	NULL
.	NULL

19	NULL
and	NULL
in	NULL
Genbank	NULL
accession	NULL
No	NULL
.	NULL

M22403	NULL
)	NULL
.	NULL

The	NULL
second	NULL
oligonu-cleotide	NULL
,	NULL
RPEX2	NULL
(	NULL
87-mer	NULL
)	NULL
,	NULL
spans	NULL
the	NULL
GP	NULL
Iba	NULL
intron	NULL
and	NULL
corresponds	NULL
to	NULL
nucleotides	NULL
2809-2829	NULL
and	NULL
nucleotides	NULL
3063-3078	NULL
.	NULL

Each	NULL
oligonucleotide	NULL
was	NULL
purified	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
labeled	NULL
with	NULL
[	NULL
y-*	NULL
``	NULL
P	NULL
]	NULL
JATP	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

Three	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
was	NULL
mixed	NULL
with	NULL
labeled	NULL
oligonucleotide	NULL
(	NULL
2	NULL
x	NULL
10*	NULL
cpm	NULL
)	NULL
in	NULL
a	NULL
buffer	NULL
composed	NULL
of	NULL
50	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
10	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
my	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
dNTP	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
spermidine	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
.	NULL

The	NULL
mixtures	NULL
were	NULL
incubated	NULL
at	NULL
80	NULL
°C	NULL
for	NULL
10	NULL
min	NULL
and	NULL
40	NULL
°C	NULL
for	NULL
2	NULL
h	NULL
to	NULL
allow	NULL
annealing	NULL
.	NULL

Two-hundred	NULL
units	NULL
of	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Molo-ney	NULL
murine	NULL
leukemia	NULL
virus	NULL
,	NULL
Life	NULL
Technologies	NULL
Inc.	NULL
)	NULL
were	NULL
added	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
incubated	NULL
at	NULL
42	NULL
°C	NULL
for	NULL
another	NULL
30	NULL
min	NULL
.	NULL

The	NULL
reaction	NULL
products	NULL
were	NULL
directly	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
through	NULL
a	NULL
denaturing	NULL
6	NULL
%	NULL
polyacrylamide-urea	NULL
sequencing	NULL
gel	NULL
.	NULL

RNase	NULL
Protection	NULL
Assay-A	NULL
recombinant	NULL
plasmid	NULL
containing	NULL
approximately	NULL
1.3	NULL
kilobases	NULL
of	NULL
the	NULL
GP	NULL
Iba	NULL
gene	NULL
was	NULL
constructed	NULL
in	NULL
the	NULL
vector	NULL
,	NULL
pBS/KS~	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
designated	NULL
pBS/ExI	NULL
.	NULL

This	NULL
plasmid	NULL
contains	NULL
1142	NULL
base	NULL
pairs	NULL
5	NULL
'	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
as	NULL
defined	NULL
by	NULL
primer	NULL
extension	NULL
analysis	NULL
)	NULL
and	NULL
includes	NULL
exon	NULL
I	NULL
of	NULL
the	NULL
GP	NULL
Iba	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

pBS/ExI	NULL
was	NULL
linearized	NULL
by	NULL
digestion	NULL
with	NULL
Stul	NULL
and	NULL
used	NULL
to	NULL
synthesize	NULL
an	NULL
RNA	NULL
probe	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
reaction	NULL
.	NULL

The	NULL
RNA	NULL
transcript	NULL
was	NULL
synthesized	NULL
in	NULL
a	NULL
30-min	NULL
reaction	NULL
(	NULL
37	NULL
°C	NULL
)	NULL
using	NULL
10	NULL
units	NULL
of	NULL
T7	NULL
RNA	NULL
polymerase	NULL
in	NULL
a	NULL
buffer	NULL
composed	NULL
of	NULL
40	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8	NULL
)	NULL
,	NULL
8	NULL
mM	NULL
MgC	NULL
]	NULL
,	NULL
2	NULL
mM	NULL
spermidine	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
0.4	NULL
mM	NULL
rATP	NULL
,	NULL
0.4	NULL
mm	NULL
rCTP	NULL
,	NULL
0.4	NULL
mM	NULL
rGTP	NULL
,	NULL
30	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
40	NULL
units	NULL
of	NULL
RNase	NULL
inhibitor	NULL
(	NULL
Strat-agene	NULL
)	NULL
,	NULL
and	NULL
50	NULL
uCi	NULL
of	NULL
[	NULL
a-*	NULL
``	NULL
P	NULL
]	NULL
rUTP	NULL
.	NULL

The	NULL
resultant	NULL
radioactive	NULL
transcript	NULL
{	NULL
approximately	NULL
200	NULL
nucleotides	NULL
in	NULL
length	NULL
)	NULL
was	NULL
purified	NULL
using	NULL
a	NULL
NucTrap	NULL
purification	NULL
column	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

The	NULL
RNase	NULL
protection	NULL
assay	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
modified	NULL
protocol	NULL
provided	NULL
by	NULL
U.	NULL
S.	NULL
Biochemical	NULL
Corp.	NULL
(	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
accompanying	NULL
their	NULL
Lysate	NULL
Ribonuclease	NULL
Protection	NULL
Kit	NULL
.	NULL

The	NULL
modification	NULL
was	NULL
the	NULL
use	NULL
of	NULL
purified	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
``	NULL
RNA	NULL
instead	NULL
of	NULL
a	NULL
cellular	NULL
lysate	NULL
suspension	NULL
.	NULL

Briefly	NULL
,	NULL
2.5	NULL
%	NULL
10°	NULL
cpm	NULL
of	NULL
RNA	NULL
probe	NULL
was	NULL
incubated	NULL
overnight	NULL
with	NULL
HEL	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
(	NULL
1.5	NULL
ug	NULL
)	NULL
in	NULL
4	NULL
M	NULL
guanidine	NULL
thiocyanate	NULL
,	NULL
0.5	NULL
%	NULL
Sarcosyl	NULL
(	NULL
45	NULL
°C	NULL
)	NULL
and	NULL
subsequently	NULL
digested	NULL
with	NULL
10	NULL
units	NULL
of	NULL
RNase	NULL
A	NULL
and	NULL
0.5	NULL
units	NULL
of	NULL
RNase	NULL
TI	NULL
(	NULL
37°C	NULL
,	NULL
30	NULL
min	NULL
)	NULL
.	NULL

The	NULL
digested	NULL
products	NULL
were	NULL
analyzed	NULL
after	NULL
denaturation	NULL
by	NULL
electrophoresis	NULL
through	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide-urea	NULL
sequencing	NULL
gel	NULL
.	NULL

Generation	NULL
of	NULL
Promoter	NULL
Constructs	NULL
of	NULL
the	NULL
Human	NULL
GP	NULL
Iba	NULL
Gene-The	NULL
isolation	NULL
of	NULL
a	NULL
6-kilobase	NULL
EcoRI	NULL
fragment	NULL
containing	NULL
the	NULL
entire	NULL
GP	NULL
Iba	NULL
gene	NULL
and	NULL
its	NULL
subcloning	NULL
into	NULL
pBS/KS~	NULL
has	NULL
been	NULL
described	NULL
(	NULL
15	NULL
)	NULL
.	NULL

This	NULL
fragment	NULL
contains	NULL
the	NULL
entire	NULL
coding	NULL
sequence	NULL
for	NULL
GP	NULL
Ibo	NULL
protein	NULL
along	NULL
with	NULL
approximately	NULL
3	NULL
kilobases	NULL
of	NULL
DNA	NULL
5	NULL
``	NULL
to	NULL
the	NULL
initiating	NULL
methionine	NULL
codon	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Previously	NULL
reported	NULL
experiments	NULL
established	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
EcoRI	NULL
fragment	NULL
to	NULL
support	NULL
the	NULL
megakaryocytic	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
GP	NULL
Iba	NULL
subunit	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
mouse	NULL
platelets	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
fragment	NULL
served	NULL
as	NULL
a	NULL
starting	NULL
point	NULL
to	NULL
identify	NULL
the	NULL
critical	NULL
components	NULL
of	NULL
the	NULL
GP	NULL
Ibe	NULL
promoter	NULL
.	NULL

First	NULL
,	NULL
the	NULL
methionine	NULL
codon	NULL
of	NULL
GP	NULL
Ibe	NULL
was	NULL
converted	NULL
to	NULL
a	NULL
HindIII	NULL
restriction	NULL
site	NULL
via	NULL
site-directed	NULL
mutagenesis	NULL
(	NULL
20	NULL
)	NULL
.	NULL

This	NULL
manipulation	NULL
allowed	NULL
the	NULL
isolation	NULL
of	NULL
a	NULL
HindIII	NULL
fragment	NULL
containing	NULL
approximately	NULL
3.1	NULL
kilobase	NULL
pairs	NULL
of	NULL
DNA	NULL
5	NULL
'	NULL
to	NULL
the	NULL
initiating	NULL
methionine	NULL
codon	NULL
.	NULL

The	NULL
HindIII	NULL
fragment	NULL
was	NULL
subcloned	NULL
into	NULL
a	NULL
p19LUC	NULL
plasmid	NULL
containing	NULL
a	NULL
promoter	NULL
less	NULL
luciferase	NULL
gene	NULL
.	NULL

This	NULL
parent	NULL
plasmid	NULL
was	NULL
designated	NULL
p-2738/LUC	NULL
since	NULL
it	NULL
contained	NULL
2,738	NULL
base	NULL
pairs	NULL
of	NULL
GP	NULL
Ibe	NULL
sequence	NULL
5	NULL
'	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Subsequent	NULL
derivatives	NULL
of	NULL
p-2738/LUC	NULL
were	NULL
generated	NULL
in	NULL
similar	NULL
site-directed	NULL
mutagenesis	NULL
experiments	NULL
by	NULL
engineering	NULL
new	NULL
HindIII	NULL
restriction	NULL
sites	NULL
at	NULL
the	NULL
various	NULL
points	NULL
through	NULL
the	NULL
promoter	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
the	NULL
nomenclature	NULL
for	NULL
each	NULL
new	NULL
recombinant	NULL
plasmid	NULL
is	NULL
based	NULL
on	NULL
the	NULL
number	NULL
of	NULL
nucleotides	NULL
5	NULL
'	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

For	NULL
example	NULL
,	NULL
p-253/LUC	NULL
contains	NULL
253	NULL
nucleotides	NULL
5	NULL
'	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

All	NULL
plasmids	NULL
used	NULL
in	NULL
transfection	NULL
analysis	NULL
were	NULL
purified	NULL
by	NULL
equilibrium	NULL
banding	NULL
in	NULL
cesium	NULL
chloride	NULL
gradients	NULL
prior	NULL
to	NULL
their	NULL
use	NULL
in	NULL
cell	NULL
transfections	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Transfection-Cell	NULL
culture	NULL
conditions	NULL
for	NULL
HEL	NULL
cells	NULL
is	NULL
as	NULL
described	NULL
above	NULL
.	NULL

HEL	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
a	NULL
Cell	NULL
Porator	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
under	NULL
conditions	NULL
established	NULL
from	NULL
pilot	NULL
exper-	NULL
24533	NULL
iments	NULL
monitoring	NULL
the	NULL
transfection	NULL
efficiency	NULL
of	NULL
a	NULL
recombinant	NULL
plasmid	NULL
expressing	NULL
luciferase	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
pro-moter	NULL
,	NULL
pRSV/LUC	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
optimized	NULL
conditions	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
40	NULL
ug	NULL
of	NULL
plasmid	NULL
,	NULL
a	NULL
field	NULL
strength	NULL
of	NULL
625	NULL
V/em	NULL
,	NULL
capacitance	NULL
330	NULL
microfar-ads	NULL
,	NULL
low	NULL
Q	NULL
,	NULL
6	NULL
x	NULL
10°	NULL
HEL	NULL
cells/ml	NULL
.	NULL

Electroporation	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
HEPES-buffered	NULL
saline	NULL
composed	NULL
of	NULL
21	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.0	NULL
)	NULL
,	NULL
137	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mm	NULL
KCl	NULL
,	NULL
0.7	NULL
mm	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
6	NULL
mM	NULL
glucose	NULL
.	NULL

Human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
(	NULL
HUVECs	NULL
)	NULL
were	NULL
collected	NULL
from	NULL
a	NULL
human	NULL
umbilical	NULL
vein	NULL
as	NULL
described	NULL
(	NULL
21	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
EGM	NULL
media	NULL
(	NULL
Clonetics	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

HUVECs	NULL
were	NULL
transfected	NULL
using	NULL
Lipofectin	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommended	NULL
conditions	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
seeded	NULL
in	NULL
60-mm	NULL
dishes	NULL
to	NULL
obtain	NULL
50	NULL
%	NULL
confluency	NULL
at	NULL
the	NULL
time	NULL
of	NULL
transfection	NULL
.	NULL

Six	NULL
ug	NULL
of	NULL
each	NULL
plasmid	NULL
was	NULL
diluted	NULL
in	NULL
OPTI-MEM	NULL
I	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
and	NULL
mixed	NULL
with	NULL
36	NULL
ug	NULL
of	NULL
Lipofectin	NULL
reagent	NULL
.	NULL

After	NULL
a	NULL
30-min	NULL
incubation	NULL
,	NULL
the	NULL
mixture	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
for	NULL
a	NULL
3-h	NULL
(	NULL
87	NULL
°C	NULL
)	NULL
incubation	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
incubator	NULL
.	NULL

Following	NULL
the	NULL
3-h	NULL
incubation	NULL
,	NULL
the	NULL
medium	NULL
was	NULL
replaced	NULL
with	NULL
complete	NULL
medium	NULL
and	NULL
left	NULL
until	NULL
time	NULL
to	NULL
harvest	NULL
the	NULL
cell	NULL
lysate	NULL
for	NULL
analysis	NULL
.	NULL

HeLa	NULL
cells	NULL
(	NULL
CCL	NULL
2	NULL
,	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

Transfection	NULL
of	NULL
HeLa	NULL
cells	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
standard	NULL
calcium	NULL
phosphate	NULL
procedure	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Luciferase	NULL
and	NULL
CAT	NULL
Assays-The	NULL
plasmid	NULL
,	NULL
pRSV/LUC	NULL
,	NULL
served	NULL
as	NULL
positive	NULL
control	NULL
plasmid	NULL
to	NULL
establish	NULL
100	NULL
%	NULL
promoter	NULL
activity	NULL
.	NULL

pRSV/	NULL
LUC	NULL
contains	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
(	NULL
RSV	NULL
)	NULL
promoter	NULL
driving	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
coding	NULL
sequence	NULL
for	NULL
luciferase	NULL
.	NULL

pRSV/CAT	NULL
was	NULL
used	NULL
in	NULL
each	NULL
transfection	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
to	NULL
normalize	NULL
transfection	NULL
effi-ciency	NULL
.	NULL

pRSV/CAT	NULL
contains	NULL
the	NULL
RSV	NULL
promoter	NULL
driving	NULL
the	NULL
expression	NULL
of	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
72	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
lysed	NULL
in	NULL
100	NULL
wl	NULL
of	NULL
50	NULL
mm	NULL
K	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
50	NULL
mm	NULL
KH	NULL
,	NULL
PO	NULL
,	NULL
,	NULL
and	NULL
0.1	NULL
M	NULL
dithiothreitol	NULL
.	NULL

After	NULL
removing	NULL
cell	NULL
debris	NULL
by	NULL
centrifugation	NULL
the	NULL
extract	NULL
was	NULL
assayed	NULL
for	NULL
luciferase	NULL
and	NULL
CAT	NULL
activity	NULL
.	NULL

Luciferase	NULL
activity	NULL
produced	NULL
by	NULL
20	NULL
pl	NULL
of	NULL
the	NULL
cell	NULL
lysate	NULL
was	NULL
determined	NULL
by	NULL
mixing	NULL
with	NULL
100	NULL
pl	NULL
of	NULL
assay	NULL
buffer	NULL
(	NULL
50	NULL
mm	NULL
K	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
50	NULL
mm	NULL
KH	NULL
,	NULL
PO	NULL
,	NULL
,	NULL
15	NULL
mm	NULL
MgSO	NULL
,	NULL
5	NULL
mM	NULL
ATP	NULL
,	NULL
1	NULL
mx	NULL
dithiothreitol	NULL
)	NULL
and	NULL
analyzing	NULL
with	NULL
a	NULL
Monolight	NULL
2010	NULL
luminometer	NULL
in	NULL
which	NULL
p-luciferin	NULL
was	NULL
automatically	NULL
injected	NULL
(	NULL
Analytical	NULL
Luminescence	NULL
Laboratory	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
amount	NULL
of	NULL
cell	NULL
extract	NULL
was	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
in	NULL
an	NULL
assay	NULL
buffer	NULL
composed	NULL
of	NULL
182	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
0.64	NULL
mM	NULL
acetyl-CoA	NULL
,	NULL
and	NULL
0.1	NULL
Ci	NULL
of	NULL
[	NULL
``	NULL
CJchloramphenicol	NULL
.	NULL

The	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
to	NULL
acetylated	NULL
chloramphenicol	NULL
was	NULL
allowed	NULL
to	NULL
proceed	NULL
for	NULL
45	NULL
min	NULL
(	NULL
87	NULL
°C	NULL
)	NULL
and	NULL
then	NULL
separated	NULL
by	NULL
thin	NULL
layer	NULL
chromatography	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
scintillation	NULL
counting	NULL
and	NULL
by	NULL
radioimaging	NULL
using	NULL
a	NULL
Phos-phorImaging	NULL
screen	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Gel	NULL
Shift	NULL
Analysis-Nine	NULL
synthetic	NULL
DNA	NULL
fragments	NULL
were	NULL
generated	NULL
as	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

These	NULL
fragments	NULL
were	NULL
synthesized	NULL
as	NULL
individual	NULL
single-stranded	NULL
oligonucleotides	NULL
and	NULL
mixed	NULL
to	NULL
allow	NULL
annealing	NULL
and	NULL
generate	NULL
each	NULL
double-stranded	NULL
fragment	NULL
.	NULL

The	NULL
mutants	NULL
oligonucleotides	NULL
used	NULL
in	NULL
gel	NULL
shift	NULL
assays	NULL
were	NULL
constructed	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
after	NULL
synthesis	NULL
of	NULL
the	NULL
corresponding	NULL
oligonucleotides	NULL
with	NULL
the	NULL
base	NULL
changes	NULL
.	NULL

Prior	NULL
to	NULL
their	NULL
use	NULL
in	NULL
gels	NULL
shift	NULL
assays	NULL
the	NULL
oligonucleotides	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
y-*	NULL
``	NULL
P	NULL
]	NULL
JATP	NULL
and	NULL
purified	NULL
through	NULL
microspin	NULL
columns	NULL
from	NULL
Phar-macia	NULL
Biotech	NULL
Inc.	NULL
(	NULL
Piscataway	NULL
,	NULL
New	NULL
Jersey	NULL
)	NULL
.	NULL

HEL	NULL
and	NULL
Hela	NULL
cell	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
washing	NULL
cells	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
followed	NULL
by	NULL
a	NULL
buffer	NULL
composed	NULL
of	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
130	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mm	NULL
KCl	NULL
,	NULL
8	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mx	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
.	NULL

The	NULL
washed	NULL
cell	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
a	NULL
hypotonic	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
5	NULL
mm	NULL
KCl	NULL
,	NULL
0.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
phenyImethylsulfonyl	NULL
fluoride	NULL
)	NULL
and	NULL
allowed	NULL
to	NULL
sit	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
lysed	NULL
in	NULL
a	NULL
Dounce	NULL
homogenizer	NULL
and	NULL
the	NULL
nuclei	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
at	NULL
1500	NULL
x	NULL
g	NULL
(	NULL
10	NULL
min	NULL
)	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
an	NULL
extraction	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
0.5	NULL
1	NULL
NaCl	NULL
,	NULL
1.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
25	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
flu-oride	NULL
,	NULL
and	NULL
5	NULL
uM	NULL
spermidine	NULL
)	NULL
and	NULL
incubated	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
extracts	NULL
were	NULL
again	NULL
centrifuged	NULL
(	NULL
10,000	NULL
x	NULL
g	NULL
,	NULL
10	NULL
min	NULL
)	NULL
to	NULL
pellet	NULL
the	NULL
cellular	NULL
debris	NULL
followed	NULL
by	NULL
dialysis	NULL
against	NULL
a	NULL
binding	NULL
buffer	NULL
composed	NULL
of	NULL
25	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
50	NULL
mm	NULL
KCl	NULL
,	NULL
0.5	NULL
mm	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
.	NULL

Approximately	NULL
1.5	NULL
ml	NULL
of	NULL
nuclear	NULL
extract	NULL
was	NULL
dialyzed	NULL
against	NULL
1.5	NULL
liters	NULL
of	NULL
binding	NULL
buffer	NULL
for	NULL
16	NULL
h	NULL
followed	NULL
by	NULL
a	NULL
change	NULL
of	NULL
buffer	NULL
and	NULL
an	NULL
additional	NULL
dialysis	NULL
for	NULL
8	NULL
h.	NULL
Each	NULL
labeled	NULL
double-stranded	NULL
fragment	NULL
(	NULL
2	NULL
x	NULL
10	NULL
``	NULL
cpm	NULL
)	NULL
was	NULL
mixed	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharma-cia	NULL
)	NULL
,	NULL
and	NULL
the	NULL
binding	NULL
buffer	NULL
listed	NULL
above	NULL
.	NULL

The	NULL
resultant	NULL
mixture	NULL
was	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Samples	NULL
were	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
in	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
prepared	NULL
in	NULL
a	NULL
running	NULL
buffer	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
24534	NULL
Functional	NULL
Analysis	NULL
of	NULL
the	NULL
Platelet	NULL
GP	NULL
Iba	NULL
Promoter	NULL
mRNA	NULL
&	NULL
//	NULL
%	NULL
1/	NULL
107	NULL
nt	NULL
BPs	NULL
j=	NULL
RPEX	NULL
2	NULL
82	NULL
nt	NULL
primer	NULL
extension	NULL
reaction	NULL
1	NULL
92	NULL
nt	NULL
nem	NULL
1772227211001	NULL
unl	NULL
c	NULL
|P	NULL
probe	NULL
RNase	NULL
protection	NULL
assay	NULL
B	NULL
C	NULL
92	NULL
--	NULL
»	NULL
|__	NULL
:	NULL
m	NULL
smae	NULL
:	NULL
.	NULL

g	NULL
<	NULL
0	NULL
4	NULL
0	NULL
-	NULL
=	NULL
+	NULL
-	NULL
Template	NULL
u	NULL
L____U	NULL
Lud	NULL
.	NULL

``	NULL
==	NULL
arexi	NULL
_	NULL
_	NULL
Primer	NULL
-	NULL
--	NULL
+	NULL
_	NULL
mRNA	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
of	NULL
the	NULL
human	NULL
GP	NULL
Iba	NULL
gene	NULL
.	NULL

A	NULL
,	NULL
the	NULL
GP	NULL
Ibe	NULL
gene	NULL
and	NULL
its	NULL
two	NULL
known	NULL
exons	NULL
are	NULL
schematically	NULL
shown	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
coding	NULL
sequence	NULL
for	NULL
the	NULL
GP	NULL
Iba	NULL
precursor	NULL
is	NULL
contained	NULL
within	NULL
exon	NULL
II	NULL
and	NULL
is	NULL
represented	NULL
by	NULL
the	NULL
filled	NULL
black	NULL
box	NULL
.	NULL

Primer	NULL
extension	NULL
analysis	NULL
(	NULL
panel	NULL
!	NULL

B	NULL
)	NULL
used	NULL
two	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
antisense	NULL
sequence	NULL
within	NULL
exon	NULL
I	NULL
(	NULL
RPEX1	NULL
)	NULL
and	NULL
antisense	NULL
sequence	NULL
spanning	NULL
exons	NULL
I	NULL
and	NULL
II	NULL
(	NULL
RPEX2	NULL
)	NULL
.	NULL

An	NULL
RNA	NULL
probe	NULL
of	NULL
approximately	NULL
200	NULL
nucleotides	NULL
in	NULL
length	NULL
was	NULL
synthesized	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
reaction	NULL
for	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
shown	NULL
in	NULL
panel	NULL
!	NULL

C.	NULL
B	NULL
,	NULL
each	NULL
oligonucleotide	NULL
was	NULL
end-labeled	NULL
with	NULL
[	NULL
y-*	NULL
``	NULL
P	NULL
]	NULL
ATP	NULL
and	NULL
annealed	NULL
to	NULL
3	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
*	NULL
)	NULL
RNA	NULL
purified	NULL
from	NULL
HEL	NULL
cells	NULL
.	NULL

After	NULL
incubation	NULL
with	NULL
reverse	NULL
transcriptase	NULL
,	NULL
the	NULL
primer	NULL
extension	NULL
products	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
6	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
HEL	NULL
poly	NULL
(	NULL
A*	NULL
)	NULL
RNA	NULL
(	NULL
Template	NULL
)	NULL
.	NULL

A	NULL
sequencing	NULL
reaction	NULL
using	NULL
the	NULL
M13	NULL
-40	NULL
universal	NULL
primer	NULL
labeled	NULL
with	NULL
[	NULL
y-	NULL
``	NULL
°P	NULL
]	NULL
JATP	NULL
and	NULL
M13	NULL
mp19	NULL
was	NULL
included	NULL
as	NULL
a	NULL
size	NULL
marker	NULL
and	NULL
is	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
.	NULL

Major	NULL
extension	NULL
products	NULL
of	NULL
82	NULL
nucleotides	NULL
and	NULL
107	NULL
nucleotides	NULL
in	NULL
length	NULL
were	NULL
observed	NULL
using	NULL
RPEX1	NULL
and	NULL
RPEX2	NULL
,	NULL
respectively	NULL
.	NULL

C	NULL
,	NULL
an	NULL
RNase	NULL
protection	NULL
assay	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
radioactive	NULL
RNA	NULL
probe	NULL
generated	NULL
from	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
reaction	NULL
and	NULL
subsequently	NULL
purified	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

The	NULL
RNA	NULL
probe	NULL
was	NULL
annealed	NULL
overnight	NULL
to	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
from	NULL
HEL	NULL
cells	NULL
and	NULL
subsequently	NULL
digested	NULL
with	NULL
RNase	NULL
A	NULL
and	NULL
RNase	NULL
TL	NULL
The	NULL
digested	NULL
products	NULL
were	NULL
denatured	NULL
and	NULL
electrophoresed	NULL
through	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide-urea	NULL
sequencing	NULL
gel	NULL
.	NULL

The	NULL
marker	NULL
(	NULL
Zeff	NULL
)	NULL
is	NULL
a	NULL
dideoxy	NULL
sequencing	NULL
reaction	NULL
using	NULL
M13	NULL
mp19	NULL
and	NULL
predicts	NULL
a	NULL
protected	NULL
RNA	NULL
species	NULL
of	NULL
92	NULL
nucleotides	NULL
in	NULL
length	NULL
.	NULL

composed	NULL
of	NULL
50	NULL
mm	NULL
Tris	NULL
(	NULL
pH	NULL
8.5	NULL
)	NULL
,	NULL
0.38	NULL
m	NULL
glycine	NULL
,	NULL
5	NULL
mm	NULL
EDTA	NULL
.	NULL

After	NULL
-	NULL
mRNA	NULL
,	NULL
we	NULL
purified	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
``	NULL
RNA	NULL
from	NULL
the	NULL
human	NULL
erythroleu-electrophoresis	NULL
,	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
.	NULL

kemic	NULL
cell	NULL
line	NULL
,	NULL
HEL	NULL
,	NULL
and	NULL
performed	NULL
primer	NULL
extension	NULL
analysis	NULL
.	NULL

RESULTS	NULL
HEL	NULL
cells	NULL
have	NULL
properties	NULL
similar	NULL
to	NULL
cells	NULL
of	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
lineages	NULL
and	NULL
have	NULL
served	NULL
as	NULL
RNA	NULL
sources	NULL
for	NULL
sequence	NULL
of	NULL
a	NULL
6062-base	NULL
pair	NULL
EcoRI	NULL
fragment	NULL
encompassing	NULL
the	NULL
cloning	NULL
cDNAs	NULL
for	NULL
a	NULL
variety	NULL
of	NULL
platelet-specific	NULL
antigens	NULL
,	NULL
in-GP	NULL
Iba	NULL
gene	NULL
has	NULL
been	NULL
previously	NULL
reported	NULL
(	NULL
19	NULL
,	NULL
23	NULL
)	NULL
.	NULL

This	NULL
anal-	NULL
cluding	NULL
the	NULL
components	NULL
of	NULL
the	NULL
GP	NULL
Ib-IX	NULL
complex	NULL
(	NULL
7-9	NULL
)	NULL
.	NULL

Anti	NULL
ysis	NULL
revealed	NULL
at	NULL
least	NULL
two	NULL
exons	NULL
,	NULL
one	NULL
exon	NULL
encoding	NULL
the	NULL
626	NULL
-	NULL
oligonucleotides	NULL
were	NULL
synthesized	NULL
corresponding	NULL
to	NULL
GP	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
GP	NULL
Iba	NULL
precursor	NULL
protein	NULL
,	NULL
preceded	NULL
by	NULL
a	NULL
Ibe	NULL
mRNA	NULL
near	NULL
the	NULL
5°	NULL
end	NULL
of	NULL
the	NULL
published	NULL
cDNA	NULL
sequence	NULL
,	NULL
Mapping	NULL
the	NULL
Site	NULL
of	NULL
Transcription	NULL
Initiation-The	NULL
nucleotide	NULL
relatively	NULL
short	NULL
intron	NULL
(	NULL
233	NULL
base	NULL
pairs	NULL
)	NULL
and	NULL
a	NULL
5'-untranslated	NULL
exon	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Our	NULL
previous	NULL
results	NULL
established	NULL
that	NULL
this	NULL
6-kilobase	NULL
fragment	NULL
contains	NULL
the	NULL
necessary	NULL
promoter	NULL
elements	NULL
to	NULL
express	NULL
human	NULL
GP	NULL
Iba	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
transgenic	NULL
mouse	NULL
platelets	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
exact	NULL
5	NULL
boundary	NULL
of	NULL
the	NULL
GP	NULL
Iba	NULL
designated	NULL
RPEX1	NULL
,	NULL
and	NULL
to	NULL
sequence	NULL
spanning	NULL
the	NULL
two	NULL
exons	NULL
,	NULL
designated	NULL
RPEX2	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
primer	NULL
extension	NULL
experiments	NULL
using	NULL
HEL	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
revealed	NULL
major	NULL
extension	NULL
products	NULL
of	NULL
82	NULL
and	NULL
107	NULL
nucleotides	NULL
using	NULL
RPEX1	NULL
and	NULL
RPEX2	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

These	NULL
fragment	NULL
lengths	NULL
map	NULL
the	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Functional	NULL
Analysis	NULL
of	NULL
the	NULL
Platelet	NULL
GP	NULL
Iba	NULL
Promoter	NULL
24535	NULL
Exd	NULL
Ex	NULL
il	NULL
I	NULL
+1	NULL
(	NULL
--	NULL
»	NULL
ors	NULL
+830	NULL
s	NULL
|	NULL
p-27381.UC	NULL
«	NULL
1142	NULL
0	NULL
-	NULL
p-114210UC	NULL
76	NULL
+330	NULL
[	NULL
-	NULL
p-7461.UC	NULL
346	NULL
0	NULL
D-	NULL
pass1uC	NULL
253	NULL
+330	NULL
[	NULL
-	NULL
p-2531.UC	NULL
140	NULL
+330	NULL
D-+330	NULL
D-	NULL
psaruc	NULL
P	NULL
+330	NULL
O-	NULL
peruc	NULL
+330	NULL
4142	NULL
|	NULL
l	NULL
p-1142invAUC	NULL
1	NULL
T	NULL
T	NULL
T	NULL
~4	NULL
0	NULL
%	NULL
10	NULL
%	NULL
20	NULL
%	NULL
30	NULL
%	NULL
40	NULL
%	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Transient	NULL
expression	NULL
analysis	NULL
of	NULL
the	NULL
GP	NULL
Iba	NULL
promoter	NULL
in	NULL
HEL	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
left	NULL
is	NULL
a	NULL
schematic	NULL
representation	NULL
of	NULL
a	NULL
series	NULL
of	NULL
GP	NULL
Iba	NULL
promoter-luciferase	NULL
constructs	NULL
that	NULL
were	NULL
generated	NULL
to	NULL
evaluate	NULL
promoter	NULL
activity	NULL
.	NULL

Each	NULL
construct	NULL
is	NULL
identified	NULL
by	NULL
the	NULL
number	NULL
of	NULL
base	NULL
pairs	NULL
5	NULL
'	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
as	NULL
shown	NULL
to	NULL
the	NULL
Zeft	NULL
of	NULL
each	NULL
promoter	NULL
fragment	NULL
.	NULL

p-1142inv/LUC	NULL
contains	NULL
the	NULL
promoter	NULL
fragment	NULL
of	NULL
p-1142/LUC	NULL
in	NULL
an	NULL
inverted	NULL
orientation	NULL
.	NULL

On	NULL
the	NULL
right	NULL
are	NULL
the	NULL
relative	NULL
luciferase	NULL
activities	NULL
of	NULL
each	NULL
plasmid	NULL
as	NULL
determined	NULL
from	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Transfection	NULL
efficiency	NULL
into	NULL
HEL	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
cotransfection	NULL
of	NULL
a	NULL
plasmid	NULL
generating	NULL
chloramphenicol	NULL
acetyltransferase	NULL
activity	NULL
and	NULL
the	NULL
results	NULL
were	NULL
normalized	NULL
for	NULL
transfection	NULL
efficiency	NULL
prior	NULL
to	NULL
determining	NULL
luciferase	NULL
activities	NULL
(	NULL
see	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
)	NULL
.	NULL

Parallel	NULL
transfections	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
promoter	NULL
driving	NULL
the	NULL
expression	NULL
of	NULL
luciferase	NULL
(	NULL
pRSV/LUC	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
generated	NULL
by	NULL
pRSV/LUC	NULL
was	NULL
arbitrarily	NULL
set	NULL
at	NULL
100	NULL
%	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
each	NULL
GP	NULL
Ibe	NULL
promoter	NULL
construct	NULL
is	NULL
reported	NULL
as	NULL
the	NULL
percent	NULL
of	NULL
the	NULL
activity	NULL
obtained	NULL
in	NULL
the	NULL
parallel	NULL
experiment	NULL
using	NULL
pRSV/LUC	NULL
.	NULL

5	NULL
'	NULL
boundary	NULL
of	NULL
the	NULL
first	NULL
GP	NULL
Iba	NULL
exon	NULL
as	NULL
nucleotide	NULL
2739	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
numbering	NULL
scheme	NULL
in	NULL
Genbank	NULL
accession	NULL
No	NULL
.	NULL

M22403	NULL
.	NULL

Additionally	NULL
,	NULL
we	NULL
performed	NULL
an	NULL
RNase	NULL
protection	NULL
assay	NULL
to	NULL
confirm	NULL
the	NULL
primer	NULL
extension	NULL
results	NULL
.	NULL

A	NULL
protected	NULL
RNA	NULL
fragment	NULL
of	NULL
92	NULL
nucleotides	NULL
in	NULL
length	NULL
was	NULL
identified	NULL
as	NULL
the	NULL
dominant	NULL
protected	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

This	NULL
result	NULL
mapped	NULL
the	NULL
5	NULL
'	NULL
boundary	NULL
of	NULL
the	NULL
first	NULL
GP	NULL
Iba	NULL
exon	NULL
to	NULL
be	NULL
one	NULL
nucleotide	NULL
further	NULL
5	NULL
'	NULL
as	NULL
compared	NULL
to	NULL
the	NULL
results	NULL
from	NULL
primer	NULL
extension	NULL
analysis	NULL
.	NULL

However	NULL
,	NULL
the	NULL
molecular	NULL
weight	NULL
determination	NULL
of	NULL
RNA	NULL
by	NULL
denaturing	NULL
gel	NULL
electrophoresis	NULL
may	NULL
vary	NULL
up	NULL
to	NULL
10	NULL
%	NULL
given	NULL
the	NULL
anomalous	NULL
mobilities	NULL
which	NULL
have	NULL
been	NULL
confirmed	NULL
using	NULL
different	NULL
electrophoretic	NULL
conditions	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
DNA	NULL
fragment	NULL
lengths	NULL
determined	NULL
by	NULL
primer	NULL
extension	NULL
analysis	NULL
are	NULL
the	NULL
more	NULL
accurate	NULL
determination	NULL
since	NULL
the	NULL
DNA	NULL
marker	NULL
is	NULL
a	NULL
similar	NULL
primer	NULL
extension	NULL
product	NULL
produced	NULL
via	NULL
a	NULL
dideoxy	NULL
sequencing	NULL
reaction	NULL
.	NULL

Cumulatively	NULL
,	NULL
these	NULL
results	NULL
establish	NULL
that	NULL
exon	NULL
I	NULL
is	NULL
91	NULL
base	NULL
pairs	NULL
in	NULL
length	NULL
and	NULL
the	NULL
GP	NULL
Iba	NULL
mRNA	NULL
contains	NULL
97	NULL
nucleotides	NULL
5	NULL
'	NULL
to	NULL
the	NULL
initiating	NULL
methionine	NULL
codon	NULL
.	NULL

Promoter	NULL
Activity	NULL
of	NULL
the	NULL
GP	NULL
Iba	NULL
Gene-As	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
a	NULL
GP	NULL
Iba	NULL
promoter	NULL
cassette	NULL
fragment	NULL
was	NULL
generated	NULL
via	NULL
site-directed	NULL
mutagenesis	NULL
to	NULL
contain	NULL
2,738	NULL
nucleotides	NULL
5	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

Additionally	NULL
,	NULL
this	NULL
fragment	NULL
contains	NULL
the	NULL
nontranslated	NULL
exon	NULL
I	NULL
,	NULL
the	NULL
single	NULL
intron	NULL
,	NULL
and	NULL
the	NULL
first	NULL
6	NULL
base	NULL
pairs	NULL
of	NULL
exon	NULL
II	NULL
which	NULL
immediately	NULL
precede	NULL
the	NULL
initiating	NULL
methionine	NULL
codon	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Luciferase	NULL
constructs	NULL
were	NULL
generated	NULL
to	NULL
evaluate	NULL
the	NULL
promoter	NULL
strength	NULL
of	NULL
this	NULL
fragment	NULL
.	NULL

The	NULL
parent	NULL
plasmid	NULL
,	NULL
p-2738/LUC	NULL
,	NULL
and	NULL
5	NULL
unidirectional	NULL
deletions	NULL
of	NULL
p-2738/LUC	NULL
were	NULL
generated	NULL
and	NULL
characterized	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
drive	NULL
the	NULL
expression	NULL
of	NULL
luciferase	NULL
activity	NULL
in	NULL
HEL	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
suggest	NULL
the	NULL
core	NULL
promoter	NULL
elements	NULL
to	NULL
be	NULL
within	NULL
the	NULL
sequence	NULL
spanning	NULL
-253	NULL
and	NULL
-63	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

Recombinant	NULL
constructs	NULL
containing	NULL
140	NULL
(	NULL
p-140/	NULL
LUC	NULL
)	NULL
,	NULL
63	NULL
(	NULL
p-63/LUC	NULL
)	NULL
,	NULL
and	NULL
6	NULL
(	NULL
p-6/LUC	NULL
)	NULL
base	NULL
pairs	NULL
preceding	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
displayed	NULL
a	NULL
progressive	NULL
loss	NULL
of	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
polarity	NULL
of	NULL
the	NULL
promoter	NULL
was	NULL
established	NULL
with	NULL
a	NULL
construct	NULL
,	NULL
designated	NULL
p-1142inv/LUC	NULL
,	NULL
in	NULL
which	NULL
the	NULL
promoter	NULL
cassette	NULL
containing	NULL
1,142	NULL
base	NULL
pairs	NULL
5	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
was	NULL
inverted	NULL
.	NULL

As	NULL
shown	NULL
,	NULL
this	NULL
construct	NULL
produces	NULL
a	NULL
basal	NULL
luciferase	NULL
activity	NULL
comparable	NULL
to	NULL
the	NULL
background	NULL
obtained	NULL
with	NULL
p-6/LUC	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Cell	NULL
Specificity	NULL
of	NULL
the	NULL
GP	NULL
Iba	NULL
Promoter-To	NULL
evaluate	NULL
promoter	NULL
strength	NULL
in	NULL
cell	NULL
types	NULL
of	NULL
nonhematopoietic	NULL
lineage	NULL
,	NULL
luciferase	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
three	NULL
different	NULL
promoter	NULL
constructs	NULL
in	NULL
HEL	NULL
,	NULL
HeLa	NULL
,	NULL
and	NULL
endothelial	NULL
cells	NULL
.	NULL

As	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
GP	NULL
Iba	NULL
constructs	NULL
had	NULL
dramatically	NULL
higher	NULL
promoter	NULL
activity	NULL
in	NULL
HEL	NULL
cells	NULL
as	NULL
compared	NULL
to	NULL
HeLa	NULL
or	NULL
endothelial	NULL
cells	NULL
,	NULL
the	NULL
later	NULL
displaying	NULL
an	NULL
activity	NULL
which	NULL
was	NULL
indistinguishable	NULL
from	NULL
background	NULL
.	NULL

To	NULL
achieve	NULL
the	NULL
highest	NULL
level	NULL
of	NULL
transfection	NULL
efficiency	NULL
in	NULL
these	NULL
experiments	NULL
it	NULL
was	NULL
necessary	NULL
to	NULL
transfect	NULL
the	NULL
cells	NULL
via	NULL
different	NULL
procedures	NULL
.	NULL

The	NULL
HEL	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
,	NULL
Hela	NULL
cells	NULL
via	NULL
a	NULL
calcium-phosphate	NULL
procedure	NULL
,	NULL
and	NULL
the	NULL
endothelial	NULL
cells	NULL
using	NULL
Lipofectin	NULL
.	NULL

The	NULL
results	NULL
are	NULL
presented	NULL
as	NULL
a	NULL
percent	NULL
of	NULL
the	NULL
100	NULL
%	NULL
activity	NULL
obtained	NULL
when	NULL
the	NULL
same	NULL
cell	NULL
type	NULL
was	NULL
transfected	NULL
with	NULL
a	NULL
luciferase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
promoter	NULL
(	NULL
pRSV/	NULL
LUC	NULL
)	NULL
.	NULL

Consensus	NULL
Binding	NULL
Motifs	NULL
within	NULL
the	NULL
253	NULL
Nucleotides	NULL
Preceding	NULL
the	NULL
Transcription	NULL
Initiation	NULL
Site-A	NULL
number	NULL
of	NULL
previously	NULL
described	NULL
promoter	NULL
binding	NULL
motifs	NULL
are	NULL
present	NULL
in	NULL
the	NULL
253	NULL
nucleotides	NULL
preceding	NULL
the	NULL
GP	NULL
Iba	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
any	NULL
of	NULL
these	NULL
putative	NULL
core	NULL
elements	NULL
contain	NULL
sequences	NULL
capable	NULL
of	NULL
specifically	NULL
interacting	NULL
with	NULL
transcription	NULL
factors	NULL
,	NULL
we	NULL
performed	NULL
gel	NULL
shift	NULL
analyses	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
we	NULL
synthesized	NULL
9	NULL
overlapping	NULL
double-stranded	NULL
frag-ments	NULL
,	NULL
as	NULL
represented	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
labeled	NULL
1	NULL
through	NULL
9	NULL
.	NULL

Individual	NULL
oligonucleotides	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
7-32P	NULL
]	NULL
ATP	NULL
,	NULL
mixed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
HEL	NULL
or	NULL
Hela	NULL
cells	NULL
,	NULL
and	NULL
electrophoresed	NULL
through	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Specific	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
24536	NULL
Functional	NULL
Analysis	NULL
of	NULL
the	NULL
Platelet	NULL
GP	NULL
Iba	NULL
Promoter	NULL
40	NULL
%	NULL
-253	NULL
-233	NULL
TTCTGGGATT	NULL
ACAGGCATGA	NULL
GCCACGCGCC	NULL
CGGCCCTgcA	NULL
©	NULL
©	NULL
HEL	NULL
cells	NULL
HeLa	NULL
cells	NULL
re	NULL
cigs	NULL
30	NULL
%	NULL
-	NULL
HUVECs	NULL
CACCC	NULL
box	NULL
,	NULL
T	NULL
GAGGTTTTTA	NULL
AAAGATGGCA	NULL
GAAGCCTGTT	NULL
TGchcGcGacTCc	NULL
(	NULL
O	NULL
&	NULL
©	NULL
-173	NULL
-153	NULL
o	NULL
AP2	NULL
ETS	NULL
motif	NULL
20	NULL
%	NULL
-	NULL
CACCCCCATC_TOGcccTeTer	NULL
AaafGCARAG	NULL
_	NULL
®	NULL
®	NULL
©	NULL
@	NULL
©	NULL
-133	NULL
-113	NULL
Ap2	NULL
inv	NULL
.	NULL

SV40	NULL
core	NULL
,	NULL
Spl	NULL
10	NULL
%	NULL
-	NULL
AACCACAAAG	NULL
-	NULL
AGGGCCTGGG_	NULL
GGaAAGCCGT	NULL
_	NULL
GGAGTGAGGC	NULL
®	NULL
®	NULL
@	NULL
@	NULL
-93	NULL
-73	NULL
GATA	NULL
NF-xB/rel	NULL
GATAAGGGCT	NULL
TGTGTCCA	NULL
0	NULL
%	NULL
®	NULL
®	NULL
p-253/LUC	NULL
p-	NULL
1421L.UC	NULL
p-2738/LUC	NULL
(	NULL
@	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Cell	NULL
specificity	NULL
of	NULL
the	NULL
GP	NULL
Ibe	NULL
promoter	NULL
.	NULL

As	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
promoter	NULL
activities	NULL
of	NULL
three	NULL
different	NULL
constructs	NULL
were	NULL
evaluated	NULL
by	NULL
transient	NULL
transfection	NULL
analysis	NULL
of	NULL
HEL	NULL
,	NULL
Hela	NULL
,	NULL
and	NULL
human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
(	NULL
HUVECs	NULL
)	NULL
.	NULL

As	NULL
before	NULL
,	NULL
the	NULL
results	NULL
are	NULL
presented	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
activity	NULL
obtained	NULL
with	NULL
parallel	NULL
transfections	NULL
using	NULL
pRSV/LUC	NULL
.	NULL

Raw	NULL
data	NULL
from	NULL
individual	NULL
experiments	NULL
using	NULL
pRSV/LUC	NULL
ranged	NULL
from	NULL
50,000	NULL
to	NULL
300,000	NULL
light	NULL
units	NULL
from	NULL
HEL	NULL
cells	NULL
;	NULL
35,000-100,000	NULL
light	NULL
units	NULL
from	NULL
HeLa	NULL
cells	NULL
;	NULL
30,000-150,000	NULL
light	NULL
units	NULL
from	NULL
HUVECs	NULL
;	NULL
and	NULL
less	NULL
than	NULL
300	NULL
light	NULL
units	NULL
from	NULL
nontransfected	NULL
cells	NULL
.	NULL

ity	NULL
for	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
was	NULL
established	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
cold	NULL
oligonucleotide	NULL
(	NULL
approximately	NULL
10-	NULL
and	NULL
100-fold	NULL
molar	NULL
excess	NULL
)	NULL
to	NULL
be	NULL
a	NULL
competitive	NULL
inhibitor	NULL
of	NULL
the	NULL
radiolabeled	NULL
fragment	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
is	NULL
a	NULL
representative	NULL
gel	NULL
shift	NULL
analysis	NULL
using	NULL
oligonucleotides	NULL
1	NULL
through	NULL
3	NULL
which	NULL
correspond	NULL
to	NULL
nucleotides	NULL
-128	NULL
to	NULL
-64	NULL
of	NULL
the	NULL
GP	NULL
Iba	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Four	NULL
major	NULL
bands	NULL
,	NULL
their	NULL
relative	NULL
mobility	NULL
positions	NULL
referred	NULL
to	NULL
as	NULL
A	NULL
through	NULL
D	NULL
,	NULL
are	NULL
considered	NULL
specific	NULL
DNA-protein	NULL
complexes	NULL
since	NULL
they	NULL
disappear	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cold	NULL
competitor	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
bands	NULL
at	NULL
position	NULL
A	NULL
were	NULL
generated	NULL
with	NULL
oligonucleotide	NULL
1	NULL
and	NULL
are	NULL
present	NULL
in	NULL
both	NULL
HEL	NULL
and	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
.	NULL

However	NULL
,	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
are	NULL
slightly	NULL
different	NULL
exhibiting	NULL
a	NULL
doublet	NULL
band	NULL
as	NULL
compared	NULL
to	NULL
a	NULL
single	NULL
band	NULL
observed	NULL
with	NULL
HEL	NULL
nuclear	NULL
extracts	NULL
.	NULL

Bands	NULL
at	NULL
positions	NULL
C	NULL
and	NULL
D	NULL
are	NULL
observed	NULL
using	NULL
oligonucleotide	NULL
2	NULL
and	NULL
are	NULL
specific	NULL
for	NULL
HEL	NULL
nuclear	NULL
extracts	NULL
(	NULL
a	NULL
comparison	NULL
of	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
bands	NULL
at	NULL
positions	NULL
C	NULL
and	NULL
D	NULL
are	NULL
always	NULL
present	NULL
together	NULL
suggesting	NULL
that	NULL
band	NULL
D	NULL
may	NULL
be	NULL
a	NULL
proteolytic	NULL
product	NULL
of	NULL
the	NULL
larger	NULL
complex	NULL
observed	NULL
at	NULL
position	NULL
C.	NULL
Bands	NULL
at	NULL
position	NULL
B	NULL
appear	NULL
with	NULL
oligonucleotides	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

In	NULL
similar	NULL
experiments	NULL
using	NULL
oligonucleotides	NULL
4-9	NULL
,	NULL
several	NULL
bands	NULL
were	NULL
observed	NULL
that	NULL
would	NULL
disappear	NULL
upon	NULL
competition	NULL
with	NULL
cold	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
observed	NULL
no	NULL
HEL-specific	NULL
complexes	NULL
using	NULL
oligonucleotides	NULL
4-9	NULL
(	NULL
comparing	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
,	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
oligonucleotide	NULL
2	NULL
produced	NULL
protein	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
5'-region	NULL
of	NULL
the	NULL
GP	NULL
Ibe	NULL
gene	NULL
.	NULL

Studies	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
demonstrate	NULL
the	NULL
core	NULL
promoter	NULL
elements	NULL
of	NULL
the	NULL
GP	NULL
Ibe	NULL
gene	NULL
to	NULL
be	NULL
within	NULL
253	NULL
nucleotides	NULL
5	NULL
``	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

A	NULL
portion	NULL
of	NULL
the	NULL
sequence	NULL
is	NULL
shown	NULL
and	NULL
a	NULL
number	NULL
of	NULL
potential	NULL
motifs	NULL
are	NULL
highlighted	NULL
that	NULL
may	NULL
represent	NULL
cis-acting	NULL
elements	NULL
within	NULL
the	NULL
GP	NULL
Iba	NULL
promoter	NULL
.	NULL

The	NULL
numbering	NULL
scheme	NULL
is	NULL
based	NULL
on	NULL
defining	NULL
the	NULL
nucleotide	NULL
immediately	NULL
5	NULL
'	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
as	NULL
-1	NULL
.	NULL

Nine	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
generated	NULL
for	NULL
analysis	NULL
in	NULL
gel	NULL
shift	NULL
assays	NULL
and	NULL
are	NULL
schematically	NULL
shown	NULL
(	NULL
labeled	NULL
.	NULL

1-9	NULL
)	NULL
.	NULL

DNA	NULL
complexes	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
HEL	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
HeLa	NULL
cells	NULL
,	NULL
prompted	NULL
further	NULL
investigation	NULL
into	NULL
the	NULL
binding	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
within	NULL
oligonucleotide	NULL
2	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
we	NULL
tested	NULL
a	NULL
potential	NULL
GATA	NULL
recognition	NULL
sequence	NULL
by	NULL
generating	NULL
a	NULL
mutant	NULL
oligonucleotide	NULL
2	NULL
containing	NULL
the	NULL
consensus	NULL
5'-GATAA-3	NULL
'	NULL
sequence	NULL
changed	NULL
to	NULL
5'-GAGCA-3	NULL
'	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
the	NULL
mutant	NULL
oligonucleotide	NULL
2	NULL
was	NULL
unable	NULL
to	NULL
compete	NULL
with	NULL
the	NULL
labeled	NULL
normal	NULL
oligonucleotide	NULL
2	NULL
for	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
at	NULL
positions	NULL
C	NULL
and	NULL
D	NULL
produced	NULL
using	NULL
HEL	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
bands	NULL
most	NULL
likely	NULL
represent	NULL
a	NULL
specific	NULL
GATA	NULL
binding	NULL
protein	NULL
interacting	NULL
with	NULL
oligonucleotide	NULL
2	NULL
.	NULL

Based	NULL
on	NULL
studies	NULL
using	NULL
other	NULL
platelet-expressed	NULL
genes	NULL
which	NULL
suggest	NULL
that	NULL
GATA	NULL
proteins	NULL
interact	NULL
with	NULL
other	NULL
regulatory	NULL
complexes	NULL
,	NULL
such	NULL
as	NULL
Ets	NULL
motifs	NULL
(	NULL
16	NULL
,	NULL
25	NULL
,	NULL
26	NULL
)	NULL
,	NULL
we	NULL
also	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
two	NULL
potential	NULL
Ets	NULL
motifs	NULL
(	NULL
5'-GGAA-3	NULL
'	NULL
)	NULL
within	NULL
the	NULL
sequence	NULL
of	NULL
oligonucleotide	NULL
5	NULL
by	NULL
generating	NULL
a	NULL
mutant	NULL
oligonucleotide	NULL
5	NULL
with	NULL
the	NULL
substitutions	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

8A	NULL
.	NULL

In	NULL
similar	NULL
experiments	NULL
to	NULL
those	NULL
described	NULL
above	NULL
,	NULL
the	NULL
mutant	NULL
oligonucleotide	NULL
5	NULL
was	NULL
unable	NULL
to	NULL
compete	NULL
for	NULL
a	NULL
DNA-protein	NULL
complex	NULL
identified	NULL
at	NULL
position	NULL
E	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
possibility	NULL
for	NULL
a	NULL
DNA-Eits-related	NULL
protein	NULL
complex	NULL
exists	NULL
in	NULL
HEL	NULL
cells	NULL
,	NULL
but	NULL
based	NULL
on	NULL
the	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
this	NULL
complex	NULL
is	NULL
not	NULL
HEL	NULL
cell-specific	NULL
.	NULL

Promoter	NULL
Strength	NULL
of	NULL
GATA	NULL
and	NULL
Ets	NULL
Mutant	NULL
Constructs-To	NULL
evaluate	NULL
directly	NULL
the	NULL
relevance	NULL
of	NULL
the	NULL
GATA	NULL
motif	NULL
within	NULL
the	NULL
GP	NULL
Iba	NULL
promoter	NULL
we	NULL
performed	NULL
site-directed	NULL
mutagenesis	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Functional	NULL
Analysis	NULL
of	NULL
the	NULL
Platelet	NULL
GP	NULL
Iba	NULL
Promoter	NULL
Probe	NULL
#	NULL
1	NULL
#	NULL
2	NULL
#	NULL
3	NULL
Competitor	NULL
#	NULL
1	NULL
#	NULL
2	NULL
#	NULL
3	NULL
-	NULL
+	NULL
[	NULL
-	NULL
+	NULL
++	NULL
]	NULL
-	NULL
+	NULL
++	NULL
Origin	NULL
|	NULL
-w	NULL
»	NULL
li	NULL
alli	NULL
ai	NULL
alin	NULL
lami	NULL
alie	NULL
ane	NULL
«	NULL
»	NULL
A	NULL
-g	NULL
»	NULL
B	NULL
-	NULL
>	NULL
is	NULL
c	NULL
-p	NULL
»	NULL
..	NULL

It	NULL
TL	NULL
Lane	NULL
1	NULL
2	NULL
8	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
24537	NULL
B	NULL
Probe	NULL
#	NULL
1	NULL
#	NULL
2	NULL
#	NULL
3	NULL
Competitor	NULL
#	NULL
14	NULL
#	NULL
2	NULL
#	NULL
3	NULL
-	NULL
4	NULL
]	NULL
-	NULL
4	NULL
apf	NULL
-	NULL
4	NULL
+	NULL
#	NULL
Origin—br-	NULL
‘	NULL
—Q	NULL
--	NULL
_..	NULL
doute	NULL
be	NULL
**	NULL
Kin	NULL
be	NULL
(	NULL
o	NULL
Lane	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Gel	NULL
shift	NULL
analyses	NULL
using	NULL
synthetic	NULL
DNA	NULL
fragments	NULL
spanning	NULL
-64	NULL
to	NULL
-128	NULL
of	NULL
the	NULL
GP	NULL
Iba	NULL
promoter	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
HEL	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

HEL	NULL
(	NULL
4	NULL
)	NULL
and	NULL
Hela	NULL
(	NULL
B	NULL
)	NULL
nuclear	NULL
extracts	NULL
were	NULL
mixed	NULL
with	NULL
radiolabeled	NULL
double-stranded	NULL
oligonucleotides	NULL
(	NULL
Probe	NULL
)	NULL
1	NULL
through	NULL
3	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
and	NULL
electrophoresed	NULL
through	NULL
native	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

After	NULL
electrophoresis	NULL
the	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
.	NULL

A	NULL
photograph	NULL
of	NULL
the	NULL
resultant	NULL
autoradiograph	NULL
is	NULL
presented	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
applied	NULL
at	NULL
the	NULL
position	NULL
labeled	NULL
Origin	NULL
.	NULL

To	NULL
evaluate	NULL
specificity	NULL
of	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
,	NULL
the	NULL
same	NULL
unlabeled	NULL
oligonucleotide	NULL
(	NULL
Competitor	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
mixture	NULL
at	NULL
10-	NULL
(	NULL
+	NULL
)	NULL
or	NULL
100-fold	NULL
(	NULL
++	NULL
)	NULL
molar	NULL
excess	NULL
.	NULL

The	NULL
migratory	NULL
positions	NULL
of	NULL
the	NULL
major	NULL
``	NULL
specific	NULL
``	NULL
complexes	NULL
are	NULL
labeled	NULL
A-D.	NULL
Probe	NULL
#	NULL
4	NULL
#	NULL
5	NULL
#	NULL
6	NULL
#	NULL
7	NULL
#	NULL
8	NULL
#	NULL
9	NULL
j	NULL
#	NULL
4	NULL
#	NULL
5	NULL
#	NULL
6	NULL
#	NULL
7	NULL
#	NULL
8	NULL
#	NULL
93	NULL
Competitor	NULL
|	NULL
_	NULL
asl	NULL
z	NULL
oael	NULL
s	NULL
sarl	NULL
s	NULL
asl	NULL
<	NULL
al	NULL
<	NULL
ap	NULL
an	NULL
aos	NULL
am	NULL
aus	NULL
die	NULL
dit	NULL
aos	NULL
aon	NULL
oon	NULL
oon	NULL
cite	NULL
dik	NULL
``	NULL
THT	NULL
till	NULL
Probe	NULL
#	NULL
4	NULL
#	NULL
5	NULL
#	NULL
6	NULL
#	NULL
7	NULL
#	NULL
8	NULL
#	NULL
9	NULL
#	NULL
4	NULL
#	NULL
5	NULL
#	NULL
6	NULL
#	NULL
47	NULL
#	NULL
8	NULL
#	NULL
9	NULL
Competitor	NULL
-	NULL
atl	NULL
s	NULL
apl	NULL
-	NULL
ap|	NULL
=	NULL
ppl	NULL
=	NULL
opp	NULL
]	NULL
-opp	NULL
wing	NULL
ame	NULL
wae	NULL
wins	NULL
(	NULL
itty	NULL
wom	NULL
wn	NULL
<	NULL
wth	NULL
wim	NULL
pil	NULL
«	NULL
ES	NULL
t	NULL
,	NULL
we	NULL
l	NULL
i	NULL
Shak	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Gel	NULL
shift	NULL
analyses	NULL
using	NULL
synthetic	NULL
DNA	NULL
fragments	NULL
spanning	NULL
-124	NULL
to	NULL
-243	NULL
of	NULL
the	NULL
GP	NULL
Iba	NULL
promoter	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
HEL	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

As	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
HEL	NULL
(	NULL
4	NULL
)	NULL
and	NULL
HeLa	NULL
(	NULL
B	NULL
)	NULL
nuclear	NULL
extracts	NULL
were	NULL
mixed	NULL
with	NULL
radiolabeled	NULL
DNA	NULL
fragments	NULL
4	NULL
through	NULL
9	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
and	NULL
electrophoresed	NULL
through	NULL
native	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

within	NULL
the	NULL
promoter	NULL
construct	NULL
containing	NULL
253	NULL
nucleotides	NULL
preceding	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
p-253/LUC	NULL
)	NULL
.	NULL

The	NULL
disruption	NULL
of	NULL
the	NULL
potential	NULL
GATA	NULL
binding	NULL
site	NULL
reduced	NULL
the	NULL
promoter	NULL
strength	NULL
from	NULL
21	NULL
to	NULL
8	NULL
%	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
provided	NULL
direct	NULL
evidence	NULL
that	NULL
the	NULL
GATA	NULL
motif	NULL
is	NULL
required	NULL
for	NULL
full	NULL
promoter	NULL
activity	NULL
,	NULL
but	NULL
also	NULL
suggested	NULL
that	NULL
additional	NULL
motifs	NULL
can	NULL
still	NULL
support	NULL
promoter	NULL
activity	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
fully	NULL
functional	NULL
GATA	NULL
.	NULL

To	NULL
test	NULL
the	NULL
role	NULL
of	NULL
the	NULL
potential	NULL
Ets	NULL
motif	NULL
,	NULL
we	NULL
prepared	NULL
a	NULL
mutant	NULL
construct	NULL
and	NULL
performed	NULL
transfection	NULL
assays	NULL
using	NULL
the	NULL
same	NULL
parent	NULL
plasmid	NULL
,	NULL
p-253/LUC	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

The	NULL
disruption	NULL
of	NULL
the	NULL
potential	NULL
Ets	NULL
motifs	NULL
reduced	NULL
the	NULL
promoter	NULL
strength	NULL
from	NULL
21	NULL
to	NULL
6	NULL
%	NULL
,	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
the	NULL
GATA	NULL
mutations	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
coordinated	NULL
effects	NULL
of	NULL
the	NULL
GATA	NULL
and	NULL
Ets	NULL
motifs	NULL
were	NULL
evident	NULL
when	NULL
the	NULL
double	NULL
mutation	NULL
,	NULL
containing	NULL
both	NULL
GATA	NULL
and	NULL
Ets	NULL
mutant	NULL
sequences	NULL
,	NULL
was	NULL
evaluated	NULL
in	NULL
a	NULL
similar	NULL
experiment	NULL
.	NULL

This	NULL
construct	NULL
resulted	NULL
in	NULL
luciferase	NULL
activity	NULL
of	NULL
less	NULL
than	NULL
0.5	NULL
%	NULL
,	NULL
a	NULL
level	NULL
indistinguishable	NULL
from	NULL
background	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
luciferase	NULL
activity	NULL
driven	NULL
by	NULL
the	NULL
plasmid	NULL
containing	NULL
both	NULL
GATA	NULL
and	NULL
Ets	NULL
mutations	NULL
was	NULL
completely	NULL
diminished	NULL
identifying	NULL
these	NULL
motifs	NULL
as	NULL
essential	NULL
elements	NULL
of	NULL
the	NULL
GP	NULL
Iba	NULL
core	NULL
promoter	NULL
.	NULL

DISCUSSION	NULL
Our	NULL
parent	NULL
plasmid	NULL
,	NULL
p-2738/LUC	NULL
,	NULL
contained	NULL
2,738	NULL
nucleotides	NULL
5	NULL
'	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
this	NULL
plasmid	NULL
contained	NULL
all	NULL
the	NULL
DNA	NULL
sequence	NULL
preceding	NULL
the	NULL
initiating	NULL
methionine	NULL
codon	NULL
of	NULL
the	NULL
precursor	NULL
protein	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
sequence	NULL
of	NULL
exon	NULL
I	NULL
,	NULL
sequence	NULL
of	NULL
the	NULL
only	NULL
intron	NULL
,	NULL
and	NULL
the	NULL
first	NULL
6	NULL
nucleotides	NULL
of	NULL
exon	NULL
II	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
p-2738/LUC	NULL
contained	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
24538	NULL
Probe	NULL
#	NULL
2	NULL
#	NULL
5	NULL
mut	NULL
.	NULL

mut	NULL
.	NULL

Competitor	NULL
#	NULL
2	NULL
#	NULL
2	NULL
#	NULL
5	NULL
#	NULL
5	NULL
-	NULL
4	NULL
+6	NULL
++	NULL
]	NULL
-	NULL
+	NULL
O	NULL
+	NULL
#	NULL
+	NULL
{	NULL
+	NULL
i+	NULL
Origin	NULL
-	NULL
>	NULL
|	NULL
sie	NULL
.	NULL

«	NULL
ots	NULL
.	NULL

aum	NULL
«	NULL
nm	NULL
A	NULL
B	NULL
c	NULL
#	NULL
D	NULL
-	NULL
»	NULL
Free	NULL
probe	NULL
-	NULL
»	NULL
Lane	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Gel	NULL
shift	NULL
analysis	NULL
using	NULL
oligonucleotides	NULL
with	NULL
potential	NULL
GATA	NULL
or	NULL
Ets	NULL
binding	NULL
motifs	NULL
and	NULL
HEL	NULL
nuclear	NULL
extracts	NULL
.	NULL

A	NULL
mutant	NULL
oligonucleotide	NULL
2	NULL
(	NULL
mut	NULL
.	NULL

#	NULL
2	NULL
)	NULL
was	NULL
prepared	NULL
and	NULL
evaluated	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
be	NULL
a	NULL
competitive	NULL
inhibitor	NULL
of	NULL
a	NULL
radioactive	NULL
oligonucleotide	NULL
2	NULL
.	NULL

Mutant	NULL
oligonucleotide	NULL
2	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
native	NULL
oligonucleotide	NULL
2	NULL
except	NULL
that	NULL
it	NULL
contains	NULL
an	NULL
altered	NULL
GATA	NULL
binding	NULL
site	NULL
(	NULL
5'-GATAA-3	NULL
'	NULL
to	NULL
5'-GAGCA-3	NULL
'	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

84	NULL
)	NULL
.	NULL

A	NULL
second	NULL
oligonucleotide	NULL
(	NULL
#	NULL
5	NULL
,	NULL
see	NULL
Figs	NULL
.	NULL

4	NULL
and	NULL
6	NULL
)	NULL
,	NULL
contains	NULL
two	NULL
potential	NULL
Ets	NULL
binding	NULL
motifs	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

The	NULL
mutant	NULL
oligonucleotide	NULL
5	NULL
was	NULL
tested	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
be	NULL
a	NULL
competitive	NULL
inhibitor	NULL
of	NULL
a	NULL
radioactive	NULL
oligonucleotide	NULL
5	NULL
containing	NULL
normal	NULL
sequence	NULL
in	NULL
a	NULL
similar	NULL
gel	NULL
shift	NULL
experiment	NULL
.	NULL

sequences	NULL
downstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
in	NULL
the	NULL
event	NULL
that	NULL
these	NULL
sequences	NULL
contributed	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

Unidirectional	NULL
deletion	NULL
analysis	NULL
of	NULL
p-2738/LUC	NULL
identified	NULL
the	NULL
shortest	NULL
construct	NULL
containing	NULL
full	NULL
promoter	NULL
activity	NULL
(	NULL
p-253/LUC	NULL
)	NULL
as	NULL
one	NULL
containing	NULL
253	NULL
nucleotides	NULL
5	NULL
'	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

The	NULL
progressive	NULL
deletion	NULL
from	NULL
-2738	NULL
to	NULL
-253	NULL
did	NULL
result	NULL
in	NULL
2-fold	NULL
,	NULL
yet	NULL
reproducible	NULL
,	NULL
differences	NULL
in	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
possibility	NULL
exists	NULL
for	NULL
positive	NULL
and	NULL
negative	NULL
enhancer	NULL
sequences	NULL
outside	NULL
the	NULL
253	NULL
nucleotides	NULL
containing	NULL
the	NULL
core	NULL
elements	NULL
of	NULL
the	NULL
GP	NULL
Iba	NULL
promoter	NULL
.	NULL

Our	NULL
studies	NULL
suggest	NULL
for	NULL
endothelial	NULL
and	NULL
Hela	NULL
cells	NULL
that	NULL
the	NULL
GP	NULL
Iba	NULL
promoter	NULL
is	NULL
only	NULL
capable	NULL
of	NULL
a	NULL
basal	NULL
level	NULL
of	NULL
transcription	NULL
that	NULL
is	NULL
indistinguishable	NULL
from	NULL
background	NULL
levels	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
in	NULL
vivo	NULL
expression	NULL
of	NULL
GP	NULL
Iba	NULL
has	NULL
not	NULL
been	NULL
systematically	NULL
evaluated	NULL
in	NULL
nonhematopoietic	NULL
cells	NULL
,	NULL
but	NULL
a	NULL
number	NULL
of	NULL
in	NULL
vitro	NULL
observations	NULL
suggest	NULL
that	NULL
GP	NULL
Ibe	NULL
mRNA	NULL
and/or	NULL
protein	NULL
expression	NULL
may	NULL
be	NULL
induced	NULL
by	NULL
cytokines	NULL
to	NULL
detectable	NULL
levels	NULL
in	NULL
endothelial	NULL
cells	NULL
and	NULL
smooth	NULL
muscle	NULL
cells	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
some	NULL
indirect	NULL
evidence	NULL
for	NULL
GP	NULL
Iba	NULL
antigen	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
activated	NULL
endothelial	NULL
cells	NULL
has	NULL
been	NULL
shown	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
bind	NULL
von	NULL
Willebrand	NULL
factor	NULL
in	NULL
a	NULL
ristocetin-dependent	NULL
manner	NULL
(	NULL
29	NULL
)	NULL
,	NULL
a	NULL
characteristic	NULL
property	NULL
of	NULL
platelet	NULL
GP	NULL
Ib-IX-V	NULL
and	NULL
its	NULL
soluble	NULL
ligand	NULL
,	NULL
von	NULL
Willebrand	NULL
factor	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

The	NULL
only	NULL
in	NULL
vivo	NULL
corollary	NULL
for	NULL
these	NULL
observations	NULL
is	NULL
an	NULL
immunological	NULL
identification	NULL
of	NULL
GP	NULL
Iba	NULL
protein	NULL
in	NULL
inflamed	NULL
tonsillar	NULL
endothelium	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
that	NULL
unstimulated	NULL
endothelial	NULL
cells	NULL
contain	NULL
a	NULL
very	NULL
low	NULL
,	NULL
yet	NULL
detectable	NULL
,	NULL
level	NULL
of	NULL
GP	NULL
Iba	NULL
mRNA	NULL
as	NULL
seen	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
a	NULL
finding	NULL
originally	NULL
reported	NULL
by	NULL
Rajagopalan	NULL
et	NULL
al	NULL
.	NULL

(	NULL
28	NULL
)	NULL
.	NULL

With	NULL
respect	NULL
to	NULL
our	NULL
presented	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
it	NULL
must	NULL
be	NULL
recognized	NULL
that	NULL
each	NULL
of	NULL
the	NULL
three	NULL
cell	NULL
types	NULL
(	NULL
HEL	NULL
,	NULL
HUVECs	NULL
,	NULL
and	NULL
Hela	NULL
)	NULL
were	NULL
transfected	NULL
via	NULL
different	NULL
procedures	NULL
in	NULL
order	NULL
to	NULL
obtain	NULL
the	NULL
highest	NULL
Functional	NULL
Analysis	NULL
of	NULL
the	NULL
Platelet	NULL
GP	NULL
Iba	NULL
Promoter	NULL
A	NULL
153	NULL
188	NULL
wild	NULL
type	NULL
___	NULL
-=	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
AAAAGGAAAGCGGAAG	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
Ets	NULL
mutant	NULL
=_	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
AAAACC	NULL
AAAGCCCAAG	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
~99	NULL
-84	NULL
Wild	NULL
typ	NULL
@	NULL
___	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
T	NULL
GAGGCGATAAGGGCT	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
GATA	NULL
mutant	NULL
T	NULL
GAGGCGAGCAGGGCT	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
B	NULL
p-253/L.UC	NULL
p-253/.UC4GATA	NULL
mut	NULL
.	NULL

p-253.UC+Ets	NULL
mut	NULL
.	NULL

p-253/.UC+GATA+Ets	NULL
mut	NULL
.	NULL

E	NULL
peruc	NULL
d	NULL
F	NULL
t	NULL
t	NULL
t	NULL
t	NULL
y	NULL
1	NULL
0	NULL
%	NULL
5	NULL
%	NULL
10	NULL
%	NULL
15	NULL
%	NULL
20	NULL
%	NULL
25	NULL
%	NULL
30	NULL
%	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Promoter	NULL
activity	NULL
of	NULL
GATA	NULL
and	NULL
Ets	NULL
mutant	NULL
promoter	NULL
constructs	NULL
.	NULL

A	NULL
,	NULL
site-directed	NULL
mutagenesis	NULL
was	NULL
performed	NULL
to	NULL
alter	NULL
the	NULL
GATA	NULL
and/or	NULL
Ets	NULL
motifs	NULL
within	NULL
the	NULL
luciferase	NULL
construct	NULL
designated	NULL
p-253/LUC	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
mutated	NULL
sequences	NULL
are	NULL
shown	NULL
below	NULL
the	NULL
native	NULL
promoter	NULL
sequence	NULL
.	NULL

The	NULL
resultant	NULL
mutant	NULL
plasmids	NULL
were	NULL
designated	NULL
p-253/LUC+GATAmut	NULL
and	NULL
p-253/LUC+Etsmut	NULL
indicating	NULL
the	NULL
alteration	NULL
of	NULL
the	NULL
potential	NULL
GATA	NULL
or	NULL
Ets	NULL
binding	NULL
site	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
single	NULL
plasmid	NULL
containing	NULL
both	NULL
GATA	NULL
and	NULL
Ets	NULL
substitutions	NULL
was	NULL
designated	NULL
p-253/LUC+GATA+Etsmut	NULL
.	NULL

B	NULL
,	NULL
the	NULL
transient	NULL
promoter	NULL
activity	NULL
in	NULL
HEL	NULL
cells	NULL
for	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
p-253/LUC	NULL
)	NULL
and	NULL
mutant	NULL
plasmids	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
experimental	NULL
methods	NULL
are	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

A	NULL
background	NULL
or	NULL
negative	NULL
control	NULL
plasmid	NULL
,	NULL
p-6/LUC	NULL
,	NULL
is	NULL
included	NULL
for	NULL
comparison	NULL
.	NULL

transfection	NULL
efficiency	NULL
for	NULL
each	NULL
cell	NULL
type	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
determination	NULL
of	NULL
GP	NULL
Iba	NULL
promoter	NULL
activity	NULL
within	NULL
each	NULL
cell	NULL
type	NULL
is	NULL
based	NULL
on	NULL
the	NULL
activity	NULL
,	NULL
assumed	NULL
to	NULL
be	NULL
maximal	NULL
,	NULL
generated	NULL
from	NULL
a	NULL
transfection	NULL
with	NULL
the	NULL
viral	NULL
promoter	NULL
in	NULL
pRSV/LUC	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
each	NULL
cell	NULL
type	NULL
responds	NULL
to	NULL
this	NULL
viral	NULL
promoter	NULL
in	NULL
a	NULL
slightly	NULL
different	NULL
manner	NULL
which	NULL
would	NULL
invalidate	NULL
comparative	NULL
conclusions	NULL
among	NULL
the	NULL
three	NULL
cell	NULL
types	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

If	NULL
fact	NULL
,	NULL
a	NULL
more	NULL
likely	NULL
explanation	NULL
is	NULL
that	NULL
the	NULL
GP	NULL
Ibe	NULL
promoter	NULL
is	NULL
somewhat	NULL
``	NULL
leaky	NULL
``	NULL
and	NULL
capable	NULL
of	NULL
a	NULL
low	NULL
level	NULL
of	NULL
transcription	NULL
in	NULL
cells	NULL
of	NULL
nonhematopoietic	NULL
lineage	NULL
.	NULL

However	NULL
,	NULL
in	NULL
light	NULL
of	NULL
the	NULL
subunit	NULL
requirements	NULL
for	NULL
efficient	NULL
surface	NULL
expression	NULL
of	NULL
a	NULL
GP	NULL
Ib-IX	NULL
complex	NULL
(	NULL
14	NULL
)	NULL
,	NULL
the	NULL
in	NULL
vivo	NULL
relevance	NULL
of	NULL
such	NULL
low	NULL
levels	NULL
of	NULL
GP	NULL
Ibe	NULL
expression	NULL
is	NULL
questionable	NULL
.	NULL

The	NULL
choice	NULL
of	NULL
HEL	NULL
cells	NULL
as	NULL
a	NULL
model	NULL
for	NULL
evaluating	NULL
gene	NULL
expression	NULL
for	NULL
components	NULL
of	NULL
the	NULL
GP	NULL
Ib-IX-V	NULL
complex	NULL
is	NULL
based	NULL
on	NULL
the	NULL
fact	NULL
that	NULL
cDNAs	NULL
for	NULL
3	NULL
subunits	NULL
of	NULL
the	NULL
complex	NULL
were	NULL
synthesized	NULL
from	NULL
HEL	NULL
mRNA	NULL
,	NULL
the	NULL
exception	NULL
being	NULL
GP	NULL
V.	NULL
It	NULL
can	NULL
argued	NULL
that	NULL
HEL	NULL
cells	NULL
are	NULL
not	NULL
a	NULL
perfect	NULL
``	NULL
model	NULL
``	NULL
megakaryocytic	NULL
cell	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
studies	NULL
evaluating	NULL
megakaryocytic-specific	NULL
promoters	NULL
have	NULL
lagged	NULL
behind	NULL
similar	NULL
studies	NULL
for	NULL
other	NULL
hemato-poietic	NULL
cells	NULL
simply	NULL
because	NULL
the	NULL
``	NULL
perfect	NULL
``	NULL
cell	NULL
line	NULL
has	NULL
not	NULL
been	NULL
identified	NULL
.	NULL

It	NULL
is	NULL
well	NULL
known	NULL
that	NULL
HEL	NULL
cells	NULL
express	NULL
genes	NULL
of	NULL
both	NULL
the	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
lineages	NULL
,	NULL
and	NULL
the	NULL
evidence	NULL
is	NULL
quite	NULL
strong	NULL
that	NULL
erythrocytic	NULL
and	NULL
megakaryocytic	NULL
lineages	NULL
derive	NULL
from	NULL
a	NULL
common	NULL
progenitor	NULL
cell	NULL
(	NULL
17	NULL
,	NULL
32	NULL
)	NULL
.	NULL

However	NULL
,	NULL
studies	NULL
of	NULL
other	NULL
platelet-specific	NULL
promoters	NULL
,	NULL
specifically	NULL
gene	NULL
promoters	NULL
for	NULL
rat	NULL
platelet	NULL
factor	NULL
4	NULL
and	NULL
the	NULL
human	NULL
platelet	NULL
GP	NULL
IIb	NULL
receptor	NULL
(	NULL
ap	NULL
,	NULL
integrin	NULL
)	NULL
,	NULL
have	NULL
utilized	NULL
HEL	NULL
cells	NULL
and	NULL
have	NULL
been	NULL
merito-	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Functional	NULL
Analysis	NULL
of	NULL
the	NULL
Platelet	NULL
GP	NULL
Iba	NULL
Promoter	NULL
rious	NULL
(	NULL
16	NULL
,	NULL
26	NULL
,	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
Block	NULL
et	NULL
al	NULL
.	NULL

(	NULL
26	NULL
)	NULL
have	NULL
determined	NULL
promoter	NULL
strength	NULL
for	NULL
the	NULL
rat	NULL
GP	NULL
IIb	NULL
promoter	NULL
by	NULL
transfecting	NULL
rat	NULL
megkaryocytes	NULL
.	NULL

Comparing	NULL
their	NULL
results	NULL
to	NULL
that	NULL
obtained	NULL
by	NULL
others	NULL
studying	NULL
the	NULL
human	NULL
GP	NULL
IIb	NULL
gene	NULL
transfected	NULL
into	NULL
HEL	NULL
cells	NULL
corroborated	NULL
the	NULL
same	NULL
promoter	NULL
elements	NULL
originally	NULL
identified	NULL
using	NULL
HEL	NULL
cells	NULL
,	NULL
but	NULL
the	NULL
actual	NULL
promoter	NULL
strength	NULL
or	NULL
quantitative	NULL
conclusions	NULL
were	NULL
significantly	NULL
different	NULL
for	NULL
the	NULL
two	NULL
cell	NULL
types	NULL
.	NULL

One	NULL
explanation	NULL
for	NULL
the	NULL
conflicting	NULL
quantitative	NULL
results	NULL
is	NULL
that	NULL
HEL	NULL
cells	NULL
express	NULL
the	NULL
same	NULL
transcription	NULL
factors	NULL
as	NULL
megakaryocytes	NULL
,	NULL
but	NULL
the	NULL
levels	NULL
of	NULL
individual	NULL
transcription	NULL
factors	NULL
differ	NULL
resulting	NULL
in	NULL
different	NULL
quantitative	NULL
conclusions	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
essential	NULL
GATA	NULL
and	NULL
Ets	NULL
binding	NULL
elements	NULL
within	NULL
the	NULL
GP	NULL
Iba	NULL
promoter	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
identifying	NULL
these	NULL
elements	NULL
as	NULL
major	NULL
regulatory	NULL
regions	NULL
in	NULL
megakaryocytic-specific	NULL
genes	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
two	NULL
previously	NULL
studied	NULL
platelet-specific	NULL
genes	NULL
,	NULL
platelet	NULL
factor	NULL
4	NULL
and	NULL
the	NULL
platelet	NULL
integrin	NULL
subunit	NULL
,	NULL
GP	NULL
IIb	NULL
(	NULL
a1	NULL
,	NULL
,	NULL
,	NULL
)	NULL
,	NULL
have	NULL
confirmed	NULL
the	NULL
important	NULL
role	NULL
of	NULL
GATA-binding	NULL
proteins	NULL
for	NULL
megakaryocytic-specific	NULL
gene	NULL
regulation	NULL
(	NULL
16	NULL
,	NULL
26	NULL
,	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

The	NULL
GATA	NULL
family	NULL
of	NULL
proteins	NULL
are	NULL
related	NULL
by	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
sequence	NULL
similarity	NULL
throughout	NULL
their	NULL
zinc	NULL
finger-binding	NULL
domains	NULL
(	NULL
35	NULL
)	NULL
.	NULL

GATA-1	NULL
is	NULL
primarily	NULL
expressed	NULL
by	NULL
mature	NULL
erythroid	NULL
cells	NULL
,	NULL
megakaryocytes	NULL
and	NULL
mast	NULL
cells	NULL
;	NULL
GATA-2	NULL
is	NULL
expressed	NULL
by	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
;	NULL
GATA-3	NULL
is	NULL
most	NULL
abundant	NULL
in	NULL
T	NULL
lymphocytes	NULL
;	NULL
and	NULL
GATA-4	NULL
is	NULL
expressed	NULL
in	NULL
endodermally-derived	NULL
tissues	NULL
and	NULL
heart	NULL
(	NULL
35-37	NULL
)	NULL
.	NULL

Our	NULL
choice	NULL
of	NULL
mutating	NULL
the	NULL
5-GATAA-3	NULL
'	NULL
site	NULL
to	NULL
5'-GAGCA-3	NULL
'	NULL
was	NULL
based	NULL
on	NULL
the	NULL
canonical	NULL
binding	NULL
site	NULL
for	NULL
GATA-1	NULL
protein	NULL
(	NULL
5'-GAT	NULL
(	NULL
A/ZT	NULL
)	NULL
-3	NULL
'	NULL
)	NULL
(	NULL
38	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
an	NULL
individual	NULL
GATA	NULL
binding	NULL
factor	NULL
can	NULL
not	NULL
be	NULL
the	NULL
sole	NULL
factor	NULL
for	NULL
megakaryocytic-specific	NULL
expression	NULL
;	NULL
in	NULL
fact	NULL
,	NULL
the	NULL
situation	NULL
may	NULL
be	NULL
much	NULL
more	NULL
complex	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Aird	NULL
et	NULL
al	NULL
.	NULL

(	NULL
39	NULL
)	NULL
have	NULL
proposed	NULL
for	NULL
platelet	NULL
factor	NULL
4	NULL
that	NULL
some	NULL
GATA	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
GATA-2	NULL
,	NULL
may	NULL
actually	NULL
inhibit	NULL
megakaryocytic	NULL
transcription	NULL
by	NULL
being	NULL
a	NULL
competitive	NULL
inhibitory	NULL
of	NULL
GATA-1	NULL
protein	NULL
.	NULL

Thus	NULL
,	NULL
by	NULL
this	NULL
scenario	NULL
the	NULL
cell	NULL
specificity	NULL
for	NULL
the	NULL
platelet	NULL
factor	NULL
4	NULL
promoter	NULL
is	NULL
not	NULL
within	NULL
the	NULL
promoter	NULL
sequence	NULL
,	NULL
but	NULL
rather	NULL
in	NULL
the	NULL
balance	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
expressed	NULL
by	NULL
the	NULL
megakaryocyte	NULL
.	NULL

Our	NULL
results	NULL
also	NULL
identified	NULL
an	NULL
essential	NULL
binding	NULL
site	NULL
for	NULL
an	NULL
Ets-related	NULL
protein	NULL
.	NULL

The	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
recognize	NULL
a	NULL
5-GGA	NULL
(	NULL
A/T	NULL
)	NULL
-3	NULL
'	NULL
motif	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
GP	NULL
Ibe	NULL
promoter	NULL
contains	NULL
two	NULL
potential	NULL
Ets	NULL
motifs	NULL
between	NULL
-138	NULL
and	NULL
-153	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Our	NULL
mutagenesis	NULL
targetted	NULL
both	NULL
potential	NULL
binding	NULL
sites	NULL
by	NULL
substituting	NULL
the	NULL
consensus	NULL
5'-GGAA-3	NULL
'	NULL
with	NULL
5'-CCAA-3	NULL
'	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
GATA	NULL
and	NULL
Ets	NULL
motifs	NULL
alone	NULL
can	NULL
not	NULL
explain	NULL
cell	NULL
specificity	NULL
as	NULL
evidenced	NULL
by	NULL
their	NULL
importance	NULL
for	NULL
expression	NULL
of	NULL
P-selectin	NULL
,	NULL
an	NULL
endothelial	NULL
cell	NULL
and	NULL
megakaryocytic	NULL
gene	NULL
product	NULL
containing	NULL
functional	NULL
GATA	NULL
and	NULL
Ets	NULL
motifs	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
requirements	NULL
for	NULL
lineage	NULL
specificity	NULL
of	NULL
these	NULL
genes	NULL
will	NULL
only	NULL
be	NULL
understood	NULL
after	NULL
the	NULL
positive	NULL
identification	NULL
of	NULL
the	NULL
specific	NULL
GATA	NULL
and	NULL
Ets	NULL
protein	NULL
interacting	NULL
with	NULL
a	NULL
specific	NULL
promoter	NULL
element	NULL
.	NULL

Identifying	NULL
the	NULL
transcription	NULL
factors	NULL
which	NULL
interact	NULL
with	NULL
the	NULL
GP	NULL
Iba	NULL
promoter	NULL
along	NULL
with	NULL
similar	NULL
studies	NULL
on	NULL
the	NULL
other	NULL
subunits	NULL
of	NULL
the	NULL
GP	NULL
Ib-IX	NULL
complex	NULL
will	NULL
provide	NULL
the	NULL
complete	NULL
description	NULL
of	NULL
the	NULL
molecular	NULL
factors	NULL
regulating	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
critical	NULL
platelet	NULL
receptor	NULL
.	NULL

As	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
the	NULL
GP	NULL
Iba	NULL
promoter	NULL
contains	NULL
a	NULL
number	NULL
of	NULL
additional	NULL
binding	NULL
motifs	NULL
for	NULL
previously	NULL
characterized	NULL
transcription	NULL
factors	NULL
.	NULL

Certainly	NULL
,	NULL
our	NULL
results	NULL
establishing	NULL
GATA	NULL
and	NULL
Ets	NULL
motifs	NULL
as	NULL
the	NULL
important	NULL
core	NULL
elements	NULL
of	NULL
the	NULL
promoter	NULL
do	NULL
not	NULL
exclude	NULL
a	NULL
potential	NULL
role	NULL
for	NULL
24539	NULL
these	NULL
other	NULL
motifs	NULL
,	NULL
but	NULL
they	NULL
do	NULL
provide	NULL
definitive	NULL
proof	NULL
for	NULL
two	NULL
of	NULL
the	NULL
key	NULL
elements	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Acknowledgments-We	NULL
are	NULL
grateful	NULL
to	NULL
the	NULL
Sam	NULL
and	NULL
Rose	NULL
Stein	NULL
Trust	NULL
Fund	NULL
for	NULL
support	NULL
establishing	NULL
the	NULL
DNA	NULL
Core	NULL
Facility	NULL
within	NULL
the	NULL
Department	NULL
of	NULL
Molecular	NULL
and	NULL
Experimental	NULL
Medicine	NULL
at	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
.	NULL

We	NULL
thank	NULL
Faye	NULL
Miller	NULL
and	NULL
Ellye	NULL
Lukaschewsky	NULL
for	NULL
their	NULL
secretarial	NULL
assistance	NULL
,	NULL
and	NULL
Jim	NULL
Roberts	NULL
for	NULL
his	NULL
technical	NULL
support	NULL
.	NULL

REFERENCES	NULL
1.	NULL
de	NULL
Sauvage	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Hass	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
Spencer	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Malloy	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
Gurney	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Spencer	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Darbonne	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Henzel	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Wong	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Kuang	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Oles	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Hultgren	NULL
,	NULL
B.	NULL
,	NULL
Solberg	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Jr.	NULL
,	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
,	NULL
and	NULL
Eaton	NULL
,	NULL
D.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
869	NULL
,	NULL
533-538	NULL
2	NULL
.	NULL

Kaushansky	NULL
,	NULL
K.	NULL
,	NULL
Lok	NULL
,	NULL
S.	NULL
,	NULL
Holly	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Broudy	NULL
,	NULL
V.	NULL
C.	NULL
,	NULL
Lin	NULL
,	NULL
N.	NULL
,	NULL
Bailey	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Forstrom	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Buddle	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Oort	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Hagen	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
Roth	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Foster	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
869	NULL
,	NULL
568-571	NULL
3	NULL
.	NULL

Wendling	NULL
,	NULL
F.	NULL
,	NULL
Maraskovsky	NULL
,	NULL
E.	NULL
,	NULL
Debili	NULL
,	NULL
N.	NULL
,	NULL
Florindo	NULL
,	NULL
C.	NULL
,	NULL
Teepe	NULL
,	NULL
M.	NULL
,	NULL
Titeux	NULL
,	NULL
M.	NULL
,	NULL
Methia	NULL
,	NULL
N.	NULL
,	NULL
Breton-Gorius	NULL
,	NULL
J.	NULL
,	NULL
Cosman	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Vainchenker	NULL
,	NULL
W.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
369	NULL
,	NULL
571-574	NULL
4	NULL
.	NULL

Shivdasani	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Rosenblatt	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Zucker-Franklin	NULL
,	NULL
D.	NULL
,	NULL
Jackson	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
Hunt	NULL
,	NULL
P.	NULL
,	NULL
Saris	NULL
,	NULL
C.	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
8	NULL
.	NULL

H.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
81	NULL
,	NULL
695-704	NULL
5	NULL
.	NULL

Nurden	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
and	NULL
Caen	NULL
,	NULL
J.	NULL
P.	NULL
(	NULL
1975	NULL
)	NULL
Nature	NULL
255	NULL
,	NULL
720-722	NULL
6	NULL
.	NULL

Caen	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Nurden	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
Jeanneau	NULL
,	NULL
C.	NULL
,	NULL
Michel	NULL
,	NULL
H.	NULL
,	NULL
Tobelem	NULL
,	NULL
G.	NULL
,	NULL
Levy-Toledano	NULL
,	NULL
S.	NULL
,	NULL
Sultan	NULL
,	NULL
Y.	NULL
,	NULL
Valensi	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Bernard	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1976	NULL
)	NULL
J	NULL
.	NULL

Lab	NULL
.	NULL

Clin	NULL
.	NULL

Med	NULL
.	NULL

87	NULL
,	NULL
586-596	NULL
7	NULL
.	NULL

Lopez	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Chung	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Fujikawa	NULL
,	NULL
K.	NULL
,	NULL
Hagen	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Roth	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
5615-5619	NULL
8	NULL
.	NULL

Lopez	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Chung	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Fujikawa	NULL
,	NULL
K.	NULL
,	NULL
Hagen	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
Davie	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
and	NULL
Roth	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
2185-2189	NULL
9	NULL
.	NULL

Hickey	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Williams	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
and	NULL
Roth	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
6773-6777	NULL
10	NULL
.	NULL

Hickey	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Hagen	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
Yagi	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Roth	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
8327-8331	NULL
11	NULL
.	NULL

Lanza	NULL
,	NULL
F.	NULL
,	NULL
Morales	NULL
,	NULL
M.	NULL
,	NULL
de	NULL
la	NULL
Salle	NULL
,	NULL
C.	NULL
,	NULL
Cazenave	NULL
,	NULL
J.	NULL
,	NULL
Clemetson	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Shimomura	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Phillips	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
20801-20807	NULL
12	NULL
.	NULL

Ruggeri	NULL
,	NULL
Z.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
in	NULL
Progress	NULL
in	NULL
Hemostasis	NULL
and	NULL
Thrombosis	NULL
(	NULL
Coller	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
ed	NULL
)	NULL
pp	NULL
.	NULL

35-68	NULL
,	NULL
W.	NULL
B.	NULL
Saunders	NULL
Co.	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
13	NULL
.	NULL

Lopez	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Blood	NULL
Cong	NULL
.	NULL

Fib	NULL
.	NULL

5	NULL
,	NULL
97-119	NULL
14	NULL
.	NULL

Lopez	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Leung	NULL
,	NULL
B.	NULL
,	NULL
Reynolds	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Li	NULL
,	NULL
C.	NULL
Q.	NULL
,	NULL
and	NULL
Fox	NULL
,	NULL
J.	NULL
E.	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
12851-12859	NULL
15	NULL
.	NULL

Ware	NULL
,	NULL
J.	NULL
,	NULL
Russell	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Marchese	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Ruggeri	NULL
,	NULL
Z.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
8376-8382	NULL
16	NULL
.	NULL

Lemarchandel	NULL
,	NULL
V.	NULL
,	NULL
Ghysdael	NULL
,	NULL
J.	NULL
,	NULL
Mignotte	NULL
,	NULL
V.	NULL
,	NULL
Rahuel	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Romeo	NULL
,	NULL
P.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
668-676	NULL
17	NULL
.	NULL

Martin	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
(	NULL
1982	NULL
)	NULL
Science	NULL
216	NULL
,	NULL
1233-1235	NULL
18	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
19	NULL
.	NULL

Wenger	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Kieffer	NULL
,	NULL
N.	NULL
,	NULL
Wicki	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
and	NULL
Clemetson	NULL
,	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

156	NULL
,	NULL
389-395	NULL
20	NULL
.	NULL

Kunkel	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Roberts	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Zakour	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

154	NULL
,	NULL
367-383	NULL
21	NULL
.	NULL

Jaffe	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Nachman	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Becker	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
and	NULL
Minick	NULL
,	NULL
C.	NULL
R.	NULL
(	NULL
1973	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

52	NULL
,	NULL
2745-2756	NULL
22	NULL
.	NULL

Chen	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Okayama	NULL
,	NULL
H.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
2745-2752	NULL
23	NULL
.	NULL

Wenger	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Wicki	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
Kieffer	NULL
,	NULL
N.	NULL
,	NULL
Adolph	NULL
,	NULL
S.	NULL
,	NULL
Hameister	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Clemetson	NULL
,	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

85	NULL
,	NULL
517-524	NULL
24	NULL
.	NULL

Lehrach	NULL
,	NULL
H.	NULL
,	NULL
Diamond	NULL
,	NULL
D.	NULL
,	NULL
Wozney	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Boedtker	NULL
,	NULL
H.	NULL
(	NULL
1977	NULL
)	NULL
Biockem-istry	NULL
16	NULL
,	NULL
4743-4751	NULL
25	NULL
.	NULL

Tymms	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Kola	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Reprod	NULL
.	NULL

Dev	NULL
.	NULL

89	NULL
,	NULL
208-214	NULL
26	NULL
.	NULL

Block	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Ravid	NULL
,	NULL
K.	NULL
,	NULL
Phung	NULL
,	NULL
Q.	NULL
H.	NULL
,	NULL
and	NULL
Poncz	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
84	NULL
,	NULL
3385-3393	NULL
27	NULL
.	NULL

Konkle	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Shapiro	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
Asch	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
and	NULL
Nachman	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
19833-19838	NULL
28	NULL
.	NULL

Rajagopalan	NULL
,	NULL
V.	NULL
,	NULL
Essex	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Shapiro	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
and	NULL
Konkle	NULL
,	NULL
B	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
153-161	NULL
29	NULL
.	NULL

Asch	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Adelman	NULL
,	NULL
B.	NULL
,	NULL
Fujimoto	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Nachman	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

81	NULL
,	NULL
1600-1607	NULL
30	NULL
.	NULL

Howard	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Sawers	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Firkin	NULL
,	NULL
B.	NULL
G.	NULL
(	NULL
1973	NULL
)	NULL
Blood	NULL
41	NULL
,	NULL
687-690	NULL
31	NULL
.	NULL

Coller	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
and	NULL
Gralnick	NULL
,	NULL
H.	NULL
R.	NULL
(	NULL
1977	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

60	NULL
,	NULL
302-312	NULL
82	NULL
.	NULL

Papayannopoulou	NULL
,	NULL
T.	NULL
,	NULL
Nakamoto	NULL
,	NULL
B.	NULL
,	NULL
Kurachi	NULL
,	NULL
S.	NULL
,	NULL
Tweeddale	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Messner	NULL
,	NULL
H.	NULL
(	NULL
1988	NULL
)	NULL
Blood	NULL
72	NULL
,	NULL
1029-1038	NULL
33	NULL
.	NULL

Ravid	NULL
,	NULL
K.	NULL
,	NULL
Doi	NULL
,	NULL
T.	NULL
,	NULL
Beeler	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Kuter	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Rosenberg	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
6116-6127	NULL
34	NULL
.	NULL

Uzan	NULL
,	NULL
G.	NULL
,	NULL
Prenant	NULL
,	NULL
M.	NULL
,	NULL
Prandini	NULL
,	NULL
M.	NULL
,	NULL
Martin	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Marguerie	NULL
,	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
8932-8939	NULL
35	NULL
.	NULL

Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
4955-4958	NULL
36	NULL
.	NULL

Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
575-581	NULL
37	NULL
.	NULL

Leonard	NULL
,	NULL
M.	NULL
,	NULL
Brice	NULL
,	NULL
M.	NULL
,	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
1071-1079	NULL
38	NULL
.	NULL

Whyatt	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
deBoer	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Grosveld	NULL
,	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
4993-5005	NULL
89	NULL
.	NULL

Aird	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Parvin	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Sharp	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Rosenberg	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
883-889	NULL
40	NULL
.	NULL

Pan	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
McEver	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
22600-22608	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Identification	NULL
of	NULL
Essential	NULL
GATA	NULL
and	NULL
Ets	NULL
Binding	NULL
Motifs	NULL
within	NULL
the	NULL
Promoter	NULL
of	NULL
the	NULL
Platelet	NULL
Glycoprotein	NULL
Ib	NULL
&	NULL
Gene	NULL
Yoshimi	NULL
Hashimoto	NULL
and	NULL
Jerry	NULL
Ware	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1995	NULL
,	NULL
270:24532-24539.	NULL
doi	NULL
:	NULL
10.1074/jb0.270.41.24532	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/270/41/24532	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
38	NULL
references	NULL
,	NULL
22	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

